{"meta":{"query_hash":"93af81fa94a8","filters":{"venue":"Crohn s & Colitis 360"},"cohort_total":64,"direct_labels_cover":0,"predictions_cover":64,"exported":64,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/93af81fa94a8","api":"https://metacan.xera.ac/api/v1/cohort?venue=Crohn+s+%26+Colitis+360"},"results":[{"id":"W2963228128","doi":"10.1093/crocol/otz014","title":"The Impact of Private Insurance Access on Nonurgent Inflammatory Bowel Disease-Related Emergency Department Use","year":2019,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Emergency department; Quartile; Confidence interval; Inflammatory bowel disease; Odds ratio; Logistic regression; Retrospective cohort study; Emergency medicine; Internal medicine; Disease","score_opus":0.009506544557702737,"score_gpt":0.270527784559207,"score_spread":0.2610212400015043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963228128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988939,0.00021429053,0.000034023196,0.00016180788,0.0000044497788,0.0000023786647,0.00033021526,0.0000016138192,0.00035732344],"genre_scores_gemma":[0.99970967,0.00004182419,0.00001697487,0.00001243649,0.0000074146533,0.0000012049543,0.00014074869,6.9952154e-7,0.00006910377],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99897087,0.00040337458,0.000087371576,0.00010536332,0.00017217049,0.00026078016],"domain_scores_gemma":[0.993089,0.0017437773,0.0034605446,0.00019736524,0.00026856648,0.0012407107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006974692,0.00014716364,0.00017459512,0.0005558973,0.00021462073,0.0005925967,0.00029341705,0.00027894884,0.003415274],"category_scores_gemma":[0.0065397946,0.00011329454,0.00068281806,0.00059732056,0.00022060866,0.0004125448,0.00068619364,0.0004717087,0.0001487491],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000854568,0.00003442916,0.9981238,0.0000053871,0.000052818687,0.00003804188,0.000014295027,0.000050363,0.000025113855,0.00002726325,0.00009334409,0.0014497621],"study_design_scores_gemma":[0.0000031994362,0.000037747624,0.9993808,0.0000058175033,0.000021524056,0.000069353075,0.000049248574,0.0003286344,0.000016083703,0.00002005048,0.00006621226,0.000001259982],"about_ca_topic_score_codex":0.008140664,"about_ca_topic_score_gemma":0.011059747,"teacher_disagreement_score":0.008140664,"about_ca_system_score_codex":0.00042463152,"about_ca_system_score_gemma":0.00040533475,"threshold_uncertainty_score":0.016186535},"labels":[],"label_agreement":null},{"id":"W2992514761","doi":"10.1093/crocol/otz050","title":"Therapeutic Drug Monitoring of Adalimumab in Patients With Inflammatory Bowel Disease","year":2019,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital Research Institute of Manitoba","funders":"","keywords":"Adalimumab; Medicine; Inflammatory bowel disease; Therapeutic drug monitoring; Drug; Inflammatory Bowel Diseases; Internal medicine; Disease; Intensive care medicine; Pharmacology","score_opus":0.0036634431316890895,"score_gpt":0.2047155842064288,"score_spread":0.2010521410747397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2992514761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9523388,0.03636662,0.0009871544,0.0009876332,0.0002039617,0.00005186384,0.00048744807,0.0001284486,0.008447973],"genre_scores_gemma":[0.9961647,0.0018298721,0.00077704544,0.00037640234,0.00011053299,0.000022101412,0.00027386023,0.000008820659,0.00043663],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99913895,0.00030185652,0.00013599344,0.00012116647,0.00023277198,0.00006922917],"domain_scores_gemma":[0.9984126,0.0005882,0.00045399868,0.000058250323,0.00020640192,0.0002805805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009162076,0.0004973751,0.0013893666,0.0010521275,0.0004789748,0.00090239634,0.00037067485,0.0007920401,0.0005915375],"category_scores_gemma":[0.0027701699,0.00019279358,0.00048591412,0.0009182282,0.00024137773,0.00051228766,0.00020116176,0.001040432,0.00024064767],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010190959,0.00037441848,0.8772829,0.00033960806,0.00033514647,0.0018961194,0.0002538342,0.00066099,0.009417229,0.00018223841,0.0015347475,0.097531825],"study_design_scores_gemma":[0.00033266153,0.0039725984,0.9725051,0.00020289727,0.00057405594,0.005975124,0.00024223783,0.0036990284,0.00557731,0.00033848718,0.0065361415,0.000044456887],"about_ca_topic_score_codex":0.0008693943,"about_ca_topic_score_gemma":0.0012113521,"teacher_disagreement_score":0.0013893666,"about_ca_system_score_codex":0.00043982008,"about_ca_system_score_gemma":0.00039799296,"threshold_uncertainty_score":0.0048454404},"labels":[],"label_agreement":null},{"id":"W2995687733","doi":"10.1093/crocol/otz053","title":"Incidence of Adverse Psychiatric Events During Treatment of Inflammatory Bowel Disease With Biologic Therapies: A Systematic Review","year":2019,"lang":"en","type":"review","venue":"Crohn s & Colitis 360","topic":"Microscopic Colitis","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Calgary; University of Manitoba","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Incidence (geometry); Adverse effect; Randomized controlled trial; Depression (economics); Anxiety; Psychosis; Inflammatory bowel disease; Psychiatry; Cohort; Internal medicine; Confidence interval; Disease; Pediatrics","score_opus":0.024588527450321664,"score_gpt":0.31735018825095423,"score_spread":0.2927616608006326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995687733","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017622863,0.9972619,0.00017653864,0.000089884474,0.000082857994,0.00016591167,0.00028794704,0.000007747444,0.00016492335],"genre_scores_gemma":[0.04047729,0.9574969,0.0007762868,0.00035327062,0.00010448735,0.00036456145,0.00029651469,0.000007480164,0.00012317245],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99416476,0.0024693082,0.0018529925,0.0004925676,0.0008617886,0.00015863434],"domain_scores_gemma":[0.9834036,0.012211797,0.002883455,0.00029123752,0.0010550213,0.00015489678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0071816975,0.0014741094,0.0096014915,0.005245946,0.0004669834,0.0020792494,0.0012510284,0.0012870547,0.0027158689],"category_scores_gemma":[0.024210611,0.0010652397,0.016038302,0.005671105,0.0005867279,0.0012048865,0.0012273168,0.0012575735,0.00020412623],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007267308,0.000019621684,0.001928353,0.8377651,0.13389125,0.000108769025,0.00007593634,0.00027459222,0.00016116371,0.00014827556,0.0008464317,0.024053745],"study_design_scores_gemma":[0.0007623897,0.00038856684,0.007010009,0.20699663,0.77598256,0.00036175034,0.00009489888,0.00021881818,0.00022720531,0.0003311627,0.007583958,0.00004203545],"about_ca_topic_score_codex":0.0068741124,"about_ca_topic_score_gemma":0.018910047,"teacher_disagreement_score":0.0096014915,"about_ca_system_score_codex":0.0022818975,"about_ca_system_score_gemma":0.0042382916,"threshold_uncertainty_score":0.037980914},"labels":[],"label_agreement":null},{"id":"W3006447266","doi":"10.1093/crocol/otaa008","title":"Oral Bran in Patients With Quiescent Ulcerative Colitis: Another Piece in the Diet Puzzle","year":2020,"lang":"en","type":"editorial","venue":"Crohn s & Colitis 360","topic":"Celiac Disease Research and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Children's Hospital Research Institute of Manitoba","funders":"","keywords":"Ulcerative colitis; Bran; Medicine; Gastroenterology; Internal medicine; Food science; Dermatology; Biology; Disease","score_opus":0.011140198746264048,"score_gpt":0.27531735513825106,"score_spread":0.264177156391987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3006447266","genre_codex":"review","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3997933,0.49753565,0.00056441675,0.08391511,0.0034583965,0.0002005294,0.001146241,0.0000565999,0.013329795],"genre_scores_gemma":[0.78693694,0.16858093,0.0022135563,0.031962346,0.006638029,0.00023757426,0.0010096554,0.000027587223,0.0023933407],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993843,0.00025790816,0.00010853799,0.00006486282,0.00012630783,0.00005808163],"domain_scores_gemma":[0.99863154,0.0006897834,0.00024399515,0.000044107062,0.00017808659,0.00021239217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011651486,0.00027659556,0.0013747031,0.00047708084,0.00040788058,0.00081626,0.00037315278,0.0011384706,0.0021958663],"category_scores_gemma":[0.0034739296,0.00015008292,0.00091073394,0.0011555078,0.00029785026,0.001061759,0.0003014127,0.0019474252,0.00029410404],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013501472,0.0015809601,0.39410755,0.0064625028,0.0017438343,0.0020787534,0.0010393901,0.00016289385,0.0011205294,0.0008322284,0.029582677,0.5477873],"study_design_scores_gemma":[0.0057850443,0.007605516,0.88169014,0.011963387,0.005808758,0.007052276,0.0047377567,0.0006691602,0.00046146105,0.0042900164,0.06977614,0.00016029694],"about_ca_topic_score_codex":0.0024270886,"about_ca_topic_score_gemma":0.005239279,"teacher_disagreement_score":0.0024270886,"about_ca_system_score_codex":0.0004158579,"about_ca_system_score_gemma":0.00050396065,"threshold_uncertainty_score":0.007345915},"labels":[],"label_agreement":null},{"id":"W3020960254","doi":"10.1093/crocol/otaa033","title":"Patient’s Perspective on Disease Burden, Remission Definition, and Symptoms Associated With Treatment Seeking: A Qualitative Study in Adult and Adolescent Patients With Crohn’s Disease","year":2020,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"Eli Lilly and Company","keywords":"Medicine; Abdominal pain; Disease; Diarrhea; Thematic analysis; Internal medicine; Population; Young adult; Crohn's disease; Qualitative research; Physical therapy; Pediatrics","score_opus":0.011616517622785563,"score_gpt":0.25374612539727054,"score_spread":0.24212960777448497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3020960254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934302,0.00094646687,0.001161998,0.0019770295,0.000053039854,0.00021342146,0.00018483128,0.000007603824,0.0020253134],"genre_scores_gemma":[0.9967625,0.0008010414,0.0007539493,0.0006522828,0.00001378394,0.00027097858,0.00007046378,0.000009671852,0.00066526467],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9895879,0.008263372,0.00038734468,0.0004063195,0.000443627,0.0009114801],"domain_scores_gemma":[0.9787744,0.016873635,0.0016253297,0.00029581095,0.001114537,0.0013162246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01447952,0.00046903262,0.00079018326,0.001263306,0.005128184,0.0031988933,0.0012457287,0.0014114616,0.0023698593],"category_scores_gemma":[0.016395895,0.00075460155,0.00056835293,0.0014947939,0.005815274,0.0034702667,0.00372843,0.0025436215,0.00024342009],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029677909,0.000024007537,0.003930408,0.00012221569,0.0000038576445,0.00047767826,0.9930894,0.000015898506,0.00032156333,0.00030137523,0.00019829637,0.0014855601],"study_design_scores_gemma":[0.00000530061,0.0000480709,0.0020766975,0.00017871836,0.0000040909076,0.00027332213,0.99443406,0.00004014632,0.000107866465,0.00010202788,0.002721164,0.000008565008],"about_ca_topic_score_codex":0.0071214214,"about_ca_topic_score_gemma":0.013283078,"teacher_disagreement_score":0.01447952,"about_ca_system_score_codex":0.004449947,"about_ca_system_score_gemma":0.0041068466,"threshold_uncertainty_score":0.076575935},"labels":[],"label_agreement":null},{"id":"W3033809361","doi":"10.1093/crocol/otaa048","title":"Inflammatory Bowel Disease and the Environment: More to Come","year":2020,"lang":"en","type":"editorial","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital Research Institute of Manitoba","funders":"","keywords":"Inflammatory bowel disease; Inflammatory Bowel Diseases; Disease; Medicine; Internal medicine","score_opus":0.003747573963178033,"score_gpt":0.21484921195287607,"score_spread":0.21110163798969803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033809361","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001754482,0.01890748,0.000056800185,0.034216303,0.9458537,0.000008090109,0.000021042642,0.000028162518,0.000890971],"genre_scores_gemma":[0.00017670095,0.007935726,0.00005279672,0.022060981,0.96601325,0.0000105903855,0.000014306971,0.000014293388,0.003721305],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9921482,0.0023199723,0.000733764,0.0007954461,0.0034989438,0.0005035865],"domain_scores_gemma":[0.9723573,0.01328371,0.0015449816,0.00072897784,0.0068658977,0.005219097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010563962,0.005174848,0.0068340353,0.004540138,0.003366387,0.010851836,0.0047357148,0.023094809,0.015360292],"category_scores_gemma":[0.024362447,0.0016026846,0.0029024815,0.0021928626,0.0037893024,0.0074366746,0.0033597846,0.024683116,0.009950694],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000061149505,0.000015178088,0.000023337334,0.0002701817,0.000023764916,0.0000986765,0.000012455401,0.000019254392,0.00003369661,0.00029910216,0.99398685,0.0051563564],"study_design_scores_gemma":[0.0001356018,0.000057211677,0.00027589785,0.0007908882,0.00009324362,0.00030825895,0.00008187538,0.00013131037,0.000046564553,0.001621629,0.996425,0.00003250587],"about_ca_topic_score_codex":0.0028128442,"about_ca_topic_score_gemma":0.009068272,"teacher_disagreement_score":0.023094809,"about_ca_system_score_codex":0.0043566097,"about_ca_system_score_gemma":0.004382274,"threshold_uncertainty_score":0.05586821},"labels":[],"label_agreement":null},{"id":"W3033916598","doi":"10.1093/crocol/otaa044","title":"Changing Patterns of Relationships Between Geographic Markers and IBD: Possible Intrusion of Obesity","year":2020,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Digestive system and related health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Obesity; Population; Vitamin D and neurology; Demography; Inflammatory bowel disease; Incidence (geometry); Latitude; Medicine; Disease; Epidemiology; Geography; Environmental health; Internal medicine","score_opus":0.019039540524481906,"score_gpt":0.24518161605397,"score_spread":0.2261420755294881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033916598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9473662,0.042532284,0.0024500324,0.0015478295,0.000054614324,0.000022874585,0.001348111,0.000023934599,0.004654113],"genre_scores_gemma":[0.9950127,0.0037270915,0.0006770254,0.000112818736,0.000040912724,0.000007186945,0.00028753115,0.0000036986935,0.00013090423],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852437,0.00074489147,0.00022429202,0.0002979249,0.0001223541,0.0000862147],"domain_scores_gemma":[0.9918032,0.0041277763,0.0026151207,0.00041675943,0.0008616314,0.0001753936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021641592,0.00014810824,0.00035284742,0.0032143523,0.00021241755,0.0012608628,0.00041309337,0.00033163224,0.0021956803],"category_scores_gemma":[0.006025917,0.00015623451,0.0004968406,0.0062541785,0.0006362619,0.0008720555,0.0005599158,0.00034018845,0.00016724879],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011140761,0.000014512101,0.9761386,0.00049052836,0.0005578674,0.00013865734,0.00036280358,0.00017448694,0.0007695421,0.00046618725,0.00020755843,0.020567806],"study_design_scores_gemma":[0.0000039027555,0.00004869833,0.99676955,0.00011844494,0.00021231685,0.00024460137,0.0009191462,0.00020071413,0.00014038078,0.00036666842,0.0009687596,0.000006817134],"about_ca_topic_score_codex":0.0032681527,"about_ca_topic_score_gemma":0.004742014,"teacher_disagreement_score":0.0032681527,"about_ca_system_score_codex":0.00025169933,"about_ca_system_score_gemma":0.00036900732,"threshold_uncertainty_score":0.011445284},"labels":[],"label_agreement":null},{"id":"W3034504576","doi":"10.1093/crocol/otaa049","title":"Randomized, Ascending Dose, Phase 2 Study of KHK4083, an Anti-OX40 Monoclonal Antibody, in Moderately Active Ulcerative Colitis","year":2020,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"Kyowa Kirin Pharmaceutical Development","keywords":"Medicine; Placebo; Ulcerative colitis; Gastroenterology; Clinical endpoint; Internal medicine; Adverse effect; Pharmacodynamics; Ascending colon; Phases of clinical research; Monoclonal antibody; Population; Randomized controlled trial; Pharmacokinetics; Clinical trial; Surgery; Antibody; Immunology; Pathology; Disease","score_opus":0.02534543814436496,"score_gpt":0.32525069056117656,"score_spread":0.2999052524168116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034504576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97770375,0.0028654537,0.0016620279,0.0009442327,0.00062800886,0.011601673,0.002006641,0.00036735984,0.0022209168],"genre_scores_gemma":[0.9609484,0.002691816,0.006091722,0.0027594138,0.0008245712,0.01670988,0.002744415,0.000090575246,0.0071392646],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99923587,0.00040297437,0.00004110456,0.0001331163,0.00006995975,0.00011700501],"domain_scores_gemma":[0.9988405,0.00025225143,0.00026127437,0.00013309345,0.00012700204,0.00038584432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021740443,0.0020228021,0.0030125168,0.00054329075,0.000545935,0.0011918207,0.001139908,0.0022055127,0.006633467],"category_scores_gemma":[0.001826728,0.0010058196,0.0010920251,0.00044639836,0.001101704,0.0011032358,0.00051354343,0.0030240256,0.0013612482],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95154744,0.020021837,0.00071850535,0.00043949444,0.00041933614,0.000059800004,0.000079702506,0.0002848375,0.011550886,0.000084171465,0.0010880455,0.013705842],"study_design_scores_gemma":[0.9080798,0.08907434,0.0013488745,0.000012038127,0.00013483009,0.000032110678,0.000009908113,0.00019908893,0.00047129107,0.00006233127,0.0005658938,0.000009331292],"about_ca_topic_score_codex":0.00056052697,"about_ca_topic_score_gemma":0.0014418715,"teacher_disagreement_score":0.006633467,"about_ca_system_score_codex":0.00060668425,"about_ca_system_score_gemma":0.0015630323,"threshold_uncertainty_score":0.022191107},"labels":[],"label_agreement":null},{"id":"W3047137954","doi":"10.1093/crocol/otaa063","title":"Maintenance Golimumab Treatment in Pediatric UC Patients With Moderately to Severely Active UC: PURSUIT PEDS PK Long-Term Study Results","year":2020,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Janssen Research and Development; Janssen Biotech; Hospital for Sick Children; Danone; Genentech; Mead Johnson Nutrition; AstraZeneca; Celgene; Biogen; Pfizer; Eli Lilly and Company","keywords":"Medicine; Golimumab; Ulcerative colitis; Interquartile range; Internal medicine; Incidence (geometry); Gastroenterology; Surgery; Pharmacokinetics; Infliximab","score_opus":0.012066425721150121,"score_gpt":0.24250840528059572,"score_spread":0.2304419795594456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047137954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99682605,0.0019344643,0.00024974762,0.000086732856,0.0000054952775,0.00010970586,0.00029866968,0.000019874726,0.00046940154],"genre_scores_gemma":[0.9978484,0.0006345272,0.0005396915,0.000090786685,0.000021667747,0.00007010389,0.00058867177,0.0000044583885,0.00020171028],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996809,0.00012279068,0.000030575247,0.000038581467,0.000076148,0.00005104871],"domain_scores_gemma":[0.99920136,0.00016306649,0.0002602048,0.00007206001,0.000099757955,0.00020362738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013865683,0.00033858736,0.0007716641,0.00015537316,0.00023450646,0.0004711894,0.00024180251,0.00026270002,0.0008814411],"category_scores_gemma":[0.0009912791,0.00012843746,0.00054947473,0.00022120221,0.00024953045,0.0004231205,0.0002807217,0.0008727559,0.0002163016],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1360557,0.014886898,0.43149233,0.0013657282,0.0022835531,0.0014971573,0.0010631171,0.0024475618,0.064093694,0.00022888381,0.00288533,0.34170005],"study_design_scores_gemma":[0.020557076,0.28278404,0.6690228,0.0001260334,0.0013450577,0.0037308505,0.00021268189,0.0023260647,0.012400581,0.00009916741,0.0073585827,0.0000370292],"about_ca_topic_score_codex":0.0004127096,"about_ca_topic_score_gemma":0.0005226678,"teacher_disagreement_score":0.0013865683,"about_ca_system_score_codex":0.0004284077,"about_ca_system_score_gemma":0.000519781,"threshold_uncertainty_score":0.0073329806},"labels":[],"label_agreement":null},{"id":"W3049275833","doi":"10.1093/crocol/otaa067","title":"Fecal Microbiota Transplantation for Ulcerative Colitis: An Evolving Therapy","year":2020,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; University of Alberta","funders":"","keywords":"Fecal bacteriotherapy; Ulcerative colitis; Feces; Transplantation; Medicine; Colitis; Internal medicine; Gastroenterology; Microbiology; Biology; Clostridium difficile; Disease; Antibiotics","score_opus":0.05053767165795414,"score_gpt":0.3251094836251865,"score_spread":0.27457181196723235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3049275833","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019425428,0.8830941,0.008307313,0.07600089,0.0036977609,0.00005986064,0.00004804037,0.00012327996,0.009243226],"genre_scores_gemma":[0.1021097,0.8277598,0.025857668,0.028269753,0.01069626,0.00008990749,0.000116940835,0.00006533409,0.005034691],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991098,0.0003472815,0.000110302426,0.00008822848,0.0002698072,0.00007464333],"domain_scores_gemma":[0.9986326,0.0005244557,0.0003226442,0.000071214155,0.00023834872,0.00021072027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027102653,0.0003755093,0.0008358494,0.00070070743,0.0004835611,0.0016122006,0.00050144043,0.0013316332,0.0025768382],"category_scores_gemma":[0.0019005863,0.000095557596,0.0005679787,0.00057082146,0.0011726784,0.0020526014,0.00090901396,0.0031365885,0.0006785771],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004104437,0.00038988746,0.0025310395,0.0024810825,0.00007748486,0.00081379694,0.00014448451,0.00039505574,0.0071365456,0.010449938,0.011065088,0.9641052],"study_design_scores_gemma":[0.00046241292,0.0074208765,0.015358556,0.013584327,0.000632696,0.017161347,0.0013100867,0.0029257773,0.0072016753,0.0391241,0.89467514,0.00014297245],"about_ca_topic_score_codex":0.0002505969,"about_ca_topic_score_gemma":0.0008608199,"teacher_disagreement_score":0.0027102653,"about_ca_system_score_codex":0.0007548731,"about_ca_system_score_gemma":0.0011236185,"threshold_uncertainty_score":0.014333427},"labels":[],"label_agreement":null},{"id":"W3093973890","doi":"10.1093/crocol/otaa085","title":"Patients’ Willingness and Perspectives Toward Chimeric Antigen Receptor T-Regulatory Cell Therapy for Inflammatory Bowel Diseases","year":2020,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; Simon Fraser University; University of British Columbia","funders":"","keywords":"Medicine; Disease; Thematic analysis; Inflammatory bowel disease; Clinical trial; Family medicine; Immunology; Internal medicine; Qualitative research","score_opus":0.010673969021678109,"score_gpt":0.21671177871409625,"score_spread":0.20603780969241814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093973890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924792,0.000499585,0.00032153437,0.003805942,0.000046046403,0.000037158377,0.000058350175,0.000006327243,0.002745795],"genre_scores_gemma":[0.9978861,0.00029017782,0.00016732271,0.0013385273,0.000021611853,0.000042008298,0.000020828722,0.000002660321,0.00023071142],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9908668,0.006883962,0.00037141537,0.00028550037,0.000827936,0.0007644081],"domain_scores_gemma":[0.97815806,0.015567724,0.00289585,0.0002832235,0.001179352,0.001915773],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009095776,0.00026662985,0.00039710748,0.00076981145,0.0017526896,0.0030377773,0.00046224744,0.0018367961,0.0037747838],"category_scores_gemma":[0.028800668,0.00023316719,0.00080277177,0.0004994332,0.001981154,0.0023695878,0.0019367314,0.002186119,0.00034900897],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072954025,0.0008199481,0.3284999,0.0008168418,0.0002555428,0.0028352733,0.5915454,0.00036953037,0.002121018,0.002732149,0.0058823465,0.06339249],"study_design_scores_gemma":[0.00010035563,0.001337056,0.09253163,0.00054274255,0.00012282586,0.0028452165,0.8836395,0.000823101,0.0006903881,0.0017019954,0.015507015,0.00015808061],"about_ca_topic_score_codex":0.0010801506,"about_ca_topic_score_gemma":0.0011262209,"teacher_disagreement_score":0.009095776,"about_ca_system_score_codex":0.0012308805,"about_ca_system_score_gemma":0.0011838903,"threshold_uncertainty_score":0.04810363},"labels":[],"label_agreement":null},{"id":"W3104299710","doi":"10.1093/crocol/otaa084","title":"Impact of Diet on Inflammatory Bowel Disease Symptoms: An Adolescent Viewpoint","year":2020,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Microscopic Colitis","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Cleveland Clinic","keywords":"Medicine; Inflammatory bowel disease; Odds ratio; Disease; Confidence interval; Internal medicine; Cross-sectional study; Crohn's disease; Physical therapy; Pathology","score_opus":0.019570834938181014,"score_gpt":0.3024873498485253,"score_spread":0.2829165149103443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3104299710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9417276,0.034653373,0.00016391049,0.012448484,0.00016354978,0.000012871316,0.00015401312,0.00000555772,0.010670702],"genre_scores_gemma":[0.9858774,0.012411784,0.00012145686,0.0009225546,0.00014895517,0.0000048553834,0.00002725818,8.7225584e-7,0.0004848871],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99985206,0.000085137355,0.000007703121,0.000010499619,0.00002516946,0.000019348863],"domain_scores_gemma":[0.9995459,0.00019772687,0.00011143062,0.000007635939,0.00005434876,0.0000829868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003549561,0.00008686351,0.00015488989,0.00023127988,0.0002010818,0.0005648454,0.00008315001,0.00040906703,0.0015843064],"category_scores_gemma":[0.0010366421,0.000065779845,0.00016723173,0.00013620377,0.00028317946,0.00031773438,0.00018240034,0.00055877195,0.00013039004],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011552539,0.00025299352,0.9439356,0.00036756916,0.00009352543,0.0012341102,0.0017881554,0.000093525254,0.0010621746,0.0008913972,0.0028705527,0.047294986],"study_design_scores_gemma":[0.000024666548,0.00082701107,0.9717202,0.0008711223,0.00016423795,0.0030688518,0.0063799047,0.00019692848,0.00040312263,0.000490591,0.015844079,0.000009253856],"about_ca_topic_score_codex":0.0020396584,"about_ca_topic_score_gemma":0.00380647,"teacher_disagreement_score":0.0020396584,"about_ca_system_score_codex":0.00020498599,"about_ca_system_score_gemma":0.00024359745,"threshold_uncertainty_score":0.0053001046},"labels":[],"label_agreement":null},{"id":"W3112937045","doi":"10.1093/crocol/otaa080","title":"Management of Inflammatory Bowel Disease Patients With Clinical Care Pathways Reduces Emergency Department Utilization","year":2020,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Emergency and Acute Care Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Crohn's and Colitis Canada","keywords":"Emergency department; Medicine; Inflammatory bowel disease; Incidence (geometry); Care pathway; Managed care; Emergency medicine; Rate ratio; Disease; Disease management; Intensive care medicine; Internal medicine; Health care; Confidence interval","score_opus":0.03630287731488946,"score_gpt":0.30457934057622793,"score_spread":0.26827646326133847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112937045","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99560803,0.0014913175,0.00020768125,0.00089235755,0.000019481875,0.000051877356,0.00029066514,0.000010251179,0.0014283842],"genre_scores_gemma":[0.9986965,0.00048506056,0.00044640806,0.00008902449,0.000022304082,0.00001798985,0.00015320873,9.722206e-7,0.000088593835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99835664,0.0009143214,0.00019759298,0.00011909922,0.00023353948,0.00017879081],"domain_scores_gemma":[0.9930299,0.0013378627,0.0042767758,0.000120013225,0.00057745894,0.0006580074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010683337,0.000112266534,0.00012844727,0.0005688439,0.00022233877,0.00073123747,0.00020921238,0.00019225116,0.002276476],"category_scores_gemma":[0.011346433,0.000075442564,0.00022938116,0.0007489163,0.00015001681,0.00052569853,0.00058031874,0.00030119988,0.00009600853],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029707904,0.0003691909,0.96643025,0.00020397372,0.00013635024,0.000093718845,0.00013729009,0.00027878783,0.00026128447,0.00014323066,0.0009178038,0.030730965],"study_design_scores_gemma":[0.000086603235,0.00082726614,0.993887,0.00029395564,0.00012891495,0.0003732103,0.00072349847,0.0008910512,0.0003347079,0.0001729273,0.0022742997,0.000006531045],"about_ca_topic_score_codex":0.0030817005,"about_ca_topic_score_gemma":0.0043066265,"teacher_disagreement_score":0.0030817005,"about_ca_system_score_codex":0.00065674767,"about_ca_system_score_gemma":0.0011793171,"threshold_uncertainty_score":0.0076155663},"labels":[],"label_agreement":null},{"id":"W3136373647","doi":"10.1093/crocol/otaa094","title":"The Genetics of Postoperative Recurrence in Crohn Disease: A Systematic Review, Meta-analysis, and Framework for Future Work","year":2020,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Alberta Health Services","keywords":"Medicine; Odds ratio; Meta-analysis; Crohn's disease; Odds; Disease; NOD2; Genotype; Internal medicine; Surgery; Logistic regression; Genetics; Biology; Gene","score_opus":0.02224698654854236,"score_gpt":0.2857195583987892,"score_spread":0.26347257185024686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3136373647","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020845823,0.9941077,0.0008434512,0.0021553466,0.0002040609,0.00016333172,0.0002197753,0.000019088302,0.00020264422],"genre_scores_gemma":[0.14470766,0.8439399,0.00566923,0.003050499,0.0007358401,0.0011111818,0.0005269194,0.00002577044,0.00023295345],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98146766,0.01181189,0.0033023234,0.0014500482,0.0013716184,0.0005964531],"domain_scores_gemma":[0.91054934,0.074826844,0.00756817,0.0021542371,0.0040953127,0.0008060394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.045231264,0.0022606289,0.011980719,0.007184966,0.0007534738,0.0044134287,0.0026264002,0.0022076522,0.0043132706],"category_scores_gemma":[0.07376008,0.0012230037,0.022347571,0.006889912,0.0013625486,0.003324099,0.0019573728,0.00214694,0.00025663106],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013197414,0.00007372205,0.022185488,0.5233643,0.38444987,0.00045786565,0.00043088492,0.0012824754,0.0003021825,0.0028752384,0.0035753872,0.059682854],"study_design_scores_gemma":[0.0006399893,0.00042654033,0.02006552,0.20767021,0.7527772,0.000321451,0.0005610655,0.0010537119,0.00013076508,0.006668877,0.009595276,0.000089380424],"about_ca_topic_score_codex":0.0078036883,"about_ca_topic_score_gemma":0.01571243,"teacher_disagreement_score":0.045231264,"about_ca_system_score_codex":0.003269374,"about_ca_system_score_gemma":0.009142801,"threshold_uncertainty_score":0.23920864},"labels":[],"label_agreement":null},{"id":"W3160713624","doi":"10.1093/crocol/otab019","title":"Certolizumab Trough Levels and Antibodies in Crohn Disease: A Single-Center Experience","year":2021,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Trough (economics); Crohn's disease; Medicine; Antibody; Single Center; Trough level; Disease; Immunology; Internal medicine","score_opus":0.020555024919639,"score_gpt":0.26614000881554034,"score_spread":0.24558498389590133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160713624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9992206,0.0004698937,0.00010069565,0.000019835279,0.0000032600135,0.000007906364,0.000026250826,0.0000020362818,0.0001494647],"genre_scores_gemma":[0.9995788,0.00019473428,0.00012421522,0.000017123328,0.000010328553,0.0000036772421,0.000039143833,0.0000012805511,0.00003065788],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992619,0.00022784152,0.00011147166,0.00017329105,0.00012135798,0.00010411141],"domain_scores_gemma":[0.9979393,0.0006834383,0.00058114616,0.0001627247,0.00015290288,0.00048054627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009090547,0.00021854149,0.000505511,0.00045913586,0.00036621475,0.0006626188,0.0002391087,0.00034170086,0.000709594],"category_scores_gemma":[0.0024609729,0.0002559288,0.0002641066,0.00063056336,0.00034545123,0.0003552025,0.00047976553,0.00034910446,0.00018224648],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036909088,0.00024139503,0.9883704,0.000035429766,0.000038533137,0.001607514,0.00027727327,0.000056460078,0.0006618041,0.000014736977,0.000099523895,0.008227818],"study_design_scores_gemma":[0.00018750071,0.0039410647,0.97031176,0.00007558121,0.00014733305,0.021209983,0.0011083415,0.0007924639,0.001191406,0.000048905862,0.00096078165,0.000024873978],"about_ca_topic_score_codex":0.0009745149,"about_ca_topic_score_gemma":0.0010605054,"teacher_disagreement_score":0.0009745149,"about_ca_system_score_codex":0.00040350136,"about_ca_system_score_gemma":0.00044784404,"threshold_uncertainty_score":0.004807651},"labels":[],"label_agreement":null},{"id":"W3166200201","doi":"10.1093/crocol/otab032","title":"Serum Ustekinumab Concentrations Are Associated With Remission in Crohn’s Disease Defined by a Serum-Based Endoscopic Healing Index","year":2021,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Interquartile range; Medicine; Gastroenterology; Quartile; Internal medicine; Crohn's disease; Receiver operating characteristic; Area under the curve; Confidence interval; Crohn disease; Ustekinumab; Surgery; Disease; Adalimumab","score_opus":0.007901095325530263,"score_gpt":0.23041292508573527,"score_spread":0.222511829760205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3166200201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984748,0.0008217968,0.00019177907,0.000050279574,0.000005863136,0.0000028639545,0.00012110174,0.0000074133804,0.0003240866],"genre_scores_gemma":[0.9996401,0.00007237573,0.00011782366,0.000014599699,0.000010641634,0.000002217233,0.00011068382,0.0000017579799,0.000029784806],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895275,0.00034392203,0.00019840358,0.00016759103,0.00022029218,0.00011697921],"domain_scores_gemma":[0.9938683,0.0021451844,0.0030845702,0.00019533289,0.00033066818,0.00037591805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010556972,0.00021031179,0.00042364703,0.00079926854,0.0001627648,0.0007565168,0.00024247571,0.00039675593,0.0016628347],"category_scores_gemma":[0.005045991,0.00014818057,0.000339713,0.00079437724,0.00033413968,0.00042197213,0.00038249712,0.00053717167,0.0002493944],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006706205,0.000031152624,0.99507755,0.000020168274,0.000050622297,0.00005364253,0.0000249469,0.000089469075,0.0007000469,0.000023311684,0.00007545341,0.0031830496],"study_design_scores_gemma":[0.000021700278,0.00017517142,0.9973794,0.000012037397,0.0000446316,0.0006264921,0.000070529044,0.0009888469,0.00043324757,0.00007820371,0.0001653753,0.0000043916166],"about_ca_topic_score_codex":0.0003385425,"about_ca_topic_score_gemma":0.00031849623,"teacher_disagreement_score":0.0016628347,"about_ca_system_score_codex":0.00019894795,"about_ca_system_score_gemma":0.00013011368,"threshold_uncertainty_score":0.005583167},"labels":[],"label_agreement":null},{"id":"W3166958902","doi":"10.1093/crocol/otab038","title":"The Great Debate With IBD Biosimilars","year":2021,"lang":"en","type":"review","venue":"Crohn s & Colitis 360","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Biosimilar; Medicine; Internal medicine","score_opus":0.04654549297425101,"score_gpt":0.3287366330887108,"score_spread":0.2821911401144598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3166958902","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000104447325,0.9740699,0.00014846049,0.02168086,0.002297162,0.0000027135945,0.000009462329,0.0000073513206,0.0016797112],"genre_scores_gemma":[0.0031360323,0.9556013,0.0003720852,0.033615634,0.005459446,0.000011569573,0.000029812112,0.000011675348,0.0017625014],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946674,0.0022019316,0.0004483092,0.00057282124,0.0018807205,0.00022882134],"domain_scores_gemma":[0.99252146,0.0052547203,0.00064695184,0.0002562908,0.0009906574,0.00032985088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007487934,0.0006726066,0.0016828834,0.0018226772,0.0009853598,0.004461917,0.001330408,0.007896238,0.005405154],"category_scores_gemma":[0.012219713,0.0003639606,0.0011452017,0.0026624063,0.0043239878,0.00815235,0.0021908893,0.009471844,0.0022704503],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015661733,0.000063153115,0.00017633814,0.01843959,0.00018213205,0.00038305382,0.0008219288,0.00022568043,0.0014187158,0.083886884,0.18491355,0.70933235],"study_design_scores_gemma":[0.00001470267,0.000028119137,0.00017194828,0.005715347,0.00003317889,0.00054072816,0.00020954093,0.000019861698,0.00013749265,0.008568049,0.984551,0.00001016],"about_ca_topic_score_codex":0.0013814055,"about_ca_topic_score_gemma":0.0013684378,"teacher_disagreement_score":0.007896238,"about_ca_system_score_codex":0.0022842046,"about_ca_system_score_gemma":0.0042566378,"threshold_uncertainty_score":0.03960049},"labels":[],"label_agreement":null},{"id":"W3170292850","doi":"10.1093/crocol/otab033","title":"Are Patient Self-reported Healthcare Utilization Data Reliable in Persons With IBD?","year":2021,"lang":"en","type":"editorial","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital Research Institute of Manitoba","funders":"","keywords":"Health care; Medicine; Psychology","score_opus":0.02428948243270657,"score_gpt":0.28377634981217503,"score_spread":0.25948686737946847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170292850","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000967306,0.022600727,0.00015451507,0.08783418,0.88813865,0.000022104796,0.00021795186,0.00003665287,0.00089852576],"genre_scores_gemma":[0.001218518,0.013410538,0.00022880475,0.048128154,0.9350775,0.000049116294,0.00010733051,0.000038422077,0.0017417069],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9810301,0.006902843,0.0037331753,0.0016665035,0.006088142,0.00057911803],"domain_scores_gemma":[0.7960137,0.14216362,0.007845804,0.0037805163,0.044480734,0.005715684],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.036514115,0.002924338,0.0059255557,0.004133613,0.0025085649,0.008426605,0.0048199086,0.019246573,0.0043623094],"category_scores_gemma":[0.14077523,0.002077824,0.003079602,0.0031146884,0.0034223609,0.0059236237,0.0016446632,0.025432695,0.0036965183],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011661703,0.000016176633,0.0003293379,0.00095908396,0.00019818789,0.00011533141,0.00003473689,0.000022285401,0.000024858458,0.00029472657,0.98589516,0.011993485],"study_design_scores_gemma":[0.0005167389,0.00013232332,0.0051799193,0.0064468854,0.0012074108,0.00058247475,0.00029419656,0.0006890283,0.00022032163,0.0027600625,0.98184997,0.0001205959],"about_ca_topic_score_codex":0.004819474,"about_ca_topic_score_gemma":0.010031607,"teacher_disagreement_score":0.9634859,"about_ca_system_score_codex":0.003706626,"about_ca_system_score_gemma":0.0049310615,"threshold_uncertainty_score":0.19310743},"labels":[],"label_agreement":null},{"id":"W3177828927","doi":"10.1093/crocol/otab043","title":"Using Patient Completed Screening Tools to Predict Risk of Malnutrition in Patients With Inflammatory Bowel Disease","year":2021,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Royal Alexandra Hospital; University of Alberta; University of Calgary","funders":"University Hospital Foundation; Government of Alberta","keywords":"Malnutrition; Medicine; Ulcerative colitis; Inflammatory bowel disease; Body mass index; Internal medicine; Receiver operating characteristic; Gold standard (test); Ambulatory; Crohn's disease; Disease","score_opus":0.03723981018318229,"score_gpt":0.2898548382395403,"score_spread":0.252615028056358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3177828927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99867094,0.00027621083,0.00014096804,0.00005517604,0.00000769094,0.000027156097,0.0003250251,0.000010237999,0.00048659582],"genre_scores_gemma":[0.9991498,0.00006395917,0.0003887236,0.0000225093,0.000005036375,0.000016357026,0.00028248437,7.770535e-7,0.000070376496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989605,0.00046519475,0.00011019259,0.00009186596,0.00026350014,0.00010876712],"domain_scores_gemma":[0.99707377,0.0009875544,0.0008809383,0.00010402787,0.0006308836,0.0003226928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014590708,0.0004504085,0.00039052364,0.0011639073,0.00025669372,0.000791547,0.00033258207,0.00039250305,0.0006653408],"category_scores_gemma":[0.0055379923,0.00017703627,0.00036531634,0.0009282544,0.00021753696,0.0003760827,0.0004584239,0.00044715856,0.00014681731],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000085488595,0.000035281035,0.9977118,0.0000114225495,0.000028467037,0.000014240994,0.000036744696,0.000057564863,0.000052476524,0.0000035343955,0.000090389665,0.0018726746],"study_design_scores_gemma":[0.000019066636,0.00024423221,0.99773705,0.000022267572,0.000029896986,0.000119350276,0.00014157321,0.001343098,0.00013821616,0.000016812675,0.0001827248,0.0000057558605],"about_ca_topic_score_codex":0.013031673,"about_ca_topic_score_gemma":0.02185673,"teacher_disagreement_score":0.013031673,"about_ca_system_score_codex":0.00046656514,"about_ca_system_score_gemma":0.00059800525,"threshold_uncertainty_score":0.02591163},"labels":[],"label_agreement":null},{"id":"W3178513091","doi":"10.1093/crocol/otab049","title":"Adalimumab, Infliximab, and Vedolizumab in Treatment of Ulcerative Colitis: A Long-Term Retrospective Study in a Tertiary Referral Center","year":2021,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Sherbrooke; Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean","funders":"","keywords":"Vedolizumab; Adalimumab; Infliximab; Medicine; Ulcerative colitis; Discontinuation; Internal medicine; Adverse effect; Retrospective cohort study; Population; Golimumab; Disease","score_opus":0.012483945811137171,"score_gpt":0.2762410478711064,"score_spread":0.2637571020599693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3178513091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99914,0.0003781812,0.000048544654,0.000046894835,0.0000040349787,0.000015499223,0.00014672782,0.0000021356977,0.00021798551],"genre_scores_gemma":[0.99938273,0.00016996374,0.000052555988,0.00008772586,0.000015107396,0.000012884878,0.00017827885,0.0000021373578,0.00009855714],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982705,0.0003685154,0.00022168896,0.00042102966,0.00041655017,0.00030166836],"domain_scores_gemma":[0.99463415,0.0008266288,0.0024657615,0.00030884737,0.00079219276,0.0009724383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011516886,0.00036672605,0.00058792304,0.001182224,0.0016762712,0.001103457,0.00076010363,0.0008294853,0.0014873474],"category_scores_gemma":[0.0030868116,0.00047429788,0.00051937765,0.0020378258,0.0008109103,0.0006550299,0.0009514083,0.000857875,0.0003121054],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004269909,0.000040106457,0.99889416,0.000007915806,0.000019642957,0.00031337567,0.00018768455,0.000009251081,0.00007226767,0.000005876303,0.000047428483,0.00035976252],"study_design_scores_gemma":[0.000011828731,0.00026374595,0.99629253,0.000016563876,0.000042326716,0.0017308986,0.0011922393,0.00010355969,0.000044345034,0.000007321492,0.0002853934,0.000009281696],"about_ca_topic_score_codex":0.050886866,"about_ca_topic_score_gemma":0.053183176,"teacher_disagreement_score":0.050886866,"about_ca_system_score_codex":0.002275119,"about_ca_system_score_gemma":0.0025991919,"threshold_uncertainty_score":0.10118133},"labels":[],"label_agreement":null},{"id":"W3201481843","doi":"10.1093/crocol/otz021","title":"Biological Treatment and the Potential Risk of Adverse Postoperative Outcome in Patients With Inflammatory Bowel Disease: An Open-Source Expert Panel Review of the Current Literature and Future Perspectives","year":2019,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Inflammatory bowel disease; Medicine; Intensive care medicine; Adverse effect; Current (fluid); Adverse Outcome Pathway; Disease; Outcome (game theory); Internal medicine; Engineering","score_opus":0.00629979692303997,"score_gpt":0.24278031332370123,"score_spread":0.23648051640066126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201481843","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009545358,0.993832,0.0003896549,0.0028337971,0.00035480753,0.00023816152,0.0005789784,0.000009292983,0.0008087813],"genre_scores_gemma":[0.019402515,0.9740545,0.0016562026,0.0031270462,0.000454512,0.00050545903,0.0005728838,0.000015120433,0.00021165656],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9776439,0.008175881,0.009255457,0.0012329761,0.003275065,0.00041673135],"domain_scores_gemma":[0.8572874,0.10658453,0.020504324,0.001662899,0.013282358,0.0006784731],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.029779444,0.0010405276,0.0045004943,0.014126989,0.00072121597,0.0031949938,0.002646756,0.0025799407,0.0051421863],"category_scores_gemma":[0.098952755,0.0007649303,0.0069631226,0.009870218,0.0010465946,0.0027282215,0.0023102795,0.0015290843,0.00058745506],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003030984,0.000028828334,0.0041923947,0.82301575,0.009777155,0.0004736363,0.0009598899,0.0002613708,0.0004152102,0.001170468,0.011880824,0.14752133],"study_design_scores_gemma":[0.000093192735,0.00007375267,0.005075105,0.90960616,0.03033937,0.00068171247,0.0006393256,0.00012210006,0.00019929295,0.0008671665,0.052241966,0.00006096756],"about_ca_topic_score_codex":0.0041886116,"about_ca_topic_score_gemma":0.011128214,"teacher_disagreement_score":0.029779444,"about_ca_system_score_codex":0.0028075967,"about_ca_system_score_gemma":0.0115755135,"threshold_uncertainty_score":0.15749067},"labels":[],"label_agreement":null},{"id":"W4224036526","doi":"10.1093/crocol/otac014","title":"Yoga in Patients With Inflammatory Bowel Disease: A Narrative Review","year":2022,"lang":"en","type":"review","venue":"Crohn s & Colitis 360","topic":"Complementary and Alternative Medicine Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Quality of life (healthcare); Psychosocial; Anxiety; Psychological intervention; Randomized controlled trial; Inflammatory bowel disease; Depression (economics); Physical therapy; Intervention (counseling); Disease; Alternative medicine; Irritable bowel syndrome; Crohn's disease; Clinical trial; Intensive care medicine; Psychiatry; Internal medicine; Nursing","score_opus":0.03851490115680113,"score_gpt":0.34332331430550245,"score_spread":0.30480841314870133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224036526","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011931953,0.9995654,0.000016003463,0.00008128276,0.000047697755,0.000014086096,0.000023376437,0.0000013758774,0.00013140729],"genre_scores_gemma":[0.0011368184,0.998516,0.000076192344,0.00012510347,0.00004787652,0.000025272933,0.00002309679,6.1303416e-7,0.000049034734],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99930894,0.0002217446,0.000224661,0.00008070636,0.00013360743,0.000030286545],"domain_scores_gemma":[0.99772805,0.0016925244,0.00035723567,0.000025049681,0.00015975487,0.000037329683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011448817,0.0009214801,0.0021986878,0.0037024743,0.00038577587,0.0014644412,0.0008299822,0.0010148822,0.0039662733],"category_scores_gemma":[0.004693418,0.0003612612,0.0018876179,0.003723746,0.00036718155,0.0010065094,0.000843127,0.00087172067,0.0003419091],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001946983,0.000044941,0.00033820508,0.70814955,0.0012697486,0.00016189092,0.00028298853,0.00011898184,0.00031001598,0.00071174186,0.008166768,0.28025046],"study_design_scores_gemma":[0.0001597537,0.0003075613,0.0057583805,0.74781084,0.012799056,0.0019802146,0.0004860694,0.00014362861,0.00023989419,0.00083026075,0.22943544,0.00004887043],"about_ca_topic_score_codex":0.0029833268,"about_ca_topic_score_gemma":0.0069238194,"teacher_disagreement_score":0.0039662733,"about_ca_system_score_codex":0.0007972012,"about_ca_system_score_gemma":0.002409629,"threshold_uncertainty_score":0.01326853},"labels":[],"label_agreement":null},{"id":"W4281781505","doi":"10.1093/crocol/otac016","title":"Impact of Bowel Urgency on Quality of Life and Clinical Outcomes in Patients With Ulcerative Colitis","year":2022,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Eli Lilly and Company","keywords":"Medicine; Ulcerative colitis; Inflammatory bowel disease; Quality of life (healthcare); Internal medicine; Calprotectin; Gastroenterology; Clinical trial; Placebo; Faecal calprotectin; Randomized controlled trial; Disease; Defecation; Physical therapy; Alternative medicine; Pathology","score_opus":0.016091006373910224,"score_gpt":0.3182580153888012,"score_spread":0.302167009014891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281781505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99201363,0.006548391,0.00008302569,0.00026380806,0.00002797969,0.000027815853,0.00031094355,0.000006673335,0.0007176623],"genre_scores_gemma":[0.99888057,0.00056765124,0.00014540639,0.000086563945,0.00002659342,0.000017597418,0.00020445384,0.0000010463754,0.000070102484],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994355,0.00025751314,0.00007056897,0.000059855473,0.0001068206,0.000069760776],"domain_scores_gemma":[0.99818534,0.00040273403,0.00095355784,0.000044024036,0.00011953538,0.00029467448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012950802,0.00029868912,0.0006212149,0.00035991654,0.00023560104,0.00050356495,0.0001725403,0.00031688128,0.0012611505],"category_scores_gemma":[0.0025343625,0.00011687766,0.00053435535,0.0005408121,0.00022316346,0.00030618964,0.00037849514,0.0006401208,0.00009882593],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0054414715,0.0004604925,0.96406645,0.00040789708,0.00092590443,0.0000987887,0.000074757394,0.00026973727,0.0009669091,0.00002703449,0.0004437192,0.02681685],"study_design_scores_gemma":[0.00016550049,0.001337205,0.99755496,0.00003801552,0.00020329088,0.00014447549,0.000035757635,0.00018443329,0.00007150501,0.000034876124,0.00022359482,0.000006324643],"about_ca_topic_score_codex":0.0004415153,"about_ca_topic_score_gemma":0.0009285556,"teacher_disagreement_score":0.0012950802,"about_ca_system_score_codex":0.00027956787,"about_ca_system_score_gemma":0.00020079307,"threshold_uncertainty_score":0.00684911},"labels":[],"label_agreement":null},{"id":"W4282960986","doi":"10.1093/crocol/otac021","title":"Indicators of Suboptimal Treatment and Associated Healthcare Costs Among Patients With Crohn’s Disease Initiated on Biologic or Conventional Agents","year":2022,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"Janssen Scientific Affairs","keywords":"Medicine; Cohort; Health care; Retrospective cohort study; Emergency medicine; Internal medicine; Healthcare system; Disease; Emergency department","score_opus":0.0156862718341254,"score_gpt":0.25853723206963486,"score_spread":0.24285096023550945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282960986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963659,0.0009118266,0.00007405872,0.00026468767,0.00000644128,0.000010836669,0.0016073843,0.0000039265637,0.00075491716],"genre_scores_gemma":[0.9985576,0.000287931,0.00012444776,0.000045837867,0.000017004146,0.000011927751,0.00089079764,0.0000012754447,0.00006306134],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989802,0.00024148024,0.00024377953,0.00012635977,0.0002522867,0.00015585398],"domain_scores_gemma":[0.99454343,0.00057213346,0.0041199266,0.00008840894,0.0002628682,0.00041328382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070631807,0.00017871619,0.00028910767,0.0012843839,0.0003371829,0.0007523764,0.00028191818,0.0003181982,0.0016479926],"category_scores_gemma":[0.0039232858,0.00014640308,0.0004605743,0.0018554803,0.0002158074,0.0006290741,0.0006544792,0.000643936,0.00013139201],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003728222,0.000009797591,0.99865806,0.000010290382,0.000022349937,0.000022188407,0.00002101269,0.000061589926,0.000012098099,0.000018071712,0.00015763668,0.00096948765],"study_design_scores_gemma":[0.000004674376,0.000036186477,0.99909234,0.000023417862,0.000016591412,0.00016794632,0.00011406302,0.00027141516,0.000018254312,0.000028312144,0.00022373833,0.0000029707494],"about_ca_topic_score_codex":0.0057182163,"about_ca_topic_score_gemma":0.00829408,"teacher_disagreement_score":0.0057182163,"about_ca_system_score_codex":0.0008712574,"about_ca_system_score_gemma":0.0006022066,"threshold_uncertainty_score":0.011369884},"labels":[],"label_agreement":null},{"id":"W4283795631","doi":"10.1093/crocol/otac025","title":"Ustekinumab Exposure in Pregnant Women From Inflammatory Bowel Disease Clinical Trials: Pregnancy Outcomes Through Up To 5 Years in Crohn’s Disease and 2 Years in Ulcerative Colitis","year":2022,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Janssen Research and Development","keywords":"Medicine; Ulcerative colitis; Ustekinumab; Inflammatory bowel disease; Pregnancy; Disease; Crohn's disease; Clinical trial; Obstetrics; Internal medicine; Gastroenterology; Infliximab","score_opus":0.05750242424892665,"score_gpt":0.37205219623180075,"score_spread":0.3145497719828741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283795631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9724401,0.021533301,0.0010427262,0.00042955254,0.000028758102,0.00023423211,0.0016285662,0.00001496054,0.0026477445],"genre_scores_gemma":[0.9949551,0.0028147057,0.00056959887,0.00013832194,0.000024167537,0.00024183458,0.00094390503,0.000004327756,0.00030794897],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944494,0.0026604505,0.0010910535,0.00053478935,0.0010366971,0.000227539],"domain_scores_gemma":[0.98695105,0.005334938,0.006468065,0.00041511725,0.0004432742,0.00038757606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010959634,0.00022410548,0.0004557527,0.0008120764,0.00035651645,0.00067461986,0.00029442948,0.0003895708,0.0013175023],"category_scores_gemma":[0.015878232,0.00017565695,0.00085581385,0.0010627705,0.00033585215,0.00052666327,0.0008586555,0.0006411074,0.00013957165],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008912521,0.00015334137,0.930698,0.0006102026,0.0008698556,0.00049965706,0.0005193756,0.00040159852,0.00095883704,0.00026564187,0.00086719927,0.05524381],"study_design_scores_gemma":[0.0005106912,0.0069998335,0.9768918,0.00050280057,0.0018235507,0.0031476712,0.00045590635,0.00064275257,0.0022988645,0.0005240501,0.006169731,0.000032210533],"about_ca_topic_score_codex":0.00054513477,"about_ca_topic_score_gemma":0.0009921602,"teacher_disagreement_score":0.010959634,"about_ca_system_score_codex":0.00056183315,"about_ca_system_score_gemma":0.00075406604,"threshold_uncertainty_score":0.05796081},"labels":[],"label_agreement":null},{"id":"W4289667225","doi":"10.1093/crocol/otac031","title":"Poor Clinician Adherence to Inflammatory Bowel Disease Guidelines: How Do We Remedy the Situation?","year":2022,"lang":"en","type":"editorial","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital Research Institute of Manitoba; McMaster University","funders":"","keywords":"Inflammatory bowel disease; Medicine; Intensive care medicine; Inflammatory Bowel Diseases; Disease; Internal medicine","score_opus":0.019039280022303463,"score_gpt":0.30368983946486977,"score_spread":0.2846505594425663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289667225","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003222896,0.0134452,0.00011310965,0.15449357,0.8308691,0.000015264226,0.00003974348,0.000041791387,0.000949989],"genre_scores_gemma":[0.00043527293,0.009875227,0.00014350623,0.075823836,0.9112405,0.00002558625,0.000025497731,0.000023815053,0.0024066188],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98674357,0.0045536677,0.0020789402,0.0010291309,0.0047451374,0.00084949064],"domain_scores_gemma":[0.8966932,0.05730502,0.006139241,0.0016711288,0.027433777,0.01075769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02141624,0.003114511,0.0054635922,0.003353466,0.00334032,0.009783372,0.0050739455,0.035589363,0.01082894],"category_scores_gemma":[0.07595118,0.0015157091,0.002901869,0.0021826976,0.0035634283,0.0069179535,0.0025093968,0.039352722,0.0076035224],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032297583,0.000011911228,0.00004062941,0.00033253597,0.000040421444,0.000077258286,0.000019665453,0.000014786501,0.000013227536,0.00023301366,0.9923636,0.0068207067],"study_design_scores_gemma":[0.00024608965,0.00007988804,0.0006606302,0.0031964425,0.00030612742,0.0003671673,0.00019680825,0.00026857844,0.00006656994,0.002148694,0.9924023,0.00006061216],"about_ca_topic_score_codex":0.0040020454,"about_ca_topic_score_gemma":0.011807712,"teacher_disagreement_score":0.035589363,"about_ca_system_score_codex":0.004375927,"about_ca_system_score_gemma":0.0068877004,"threshold_uncertainty_score":0.11326122},"labels":[],"label_agreement":null},{"id":"W4296700750","doi":"10.1093/crocol/otac036","title":"Exploring Patient Perspectives on a 12-Week Online, Stress Reduction Intervention in Inflammatory Bowel Disease","year":2022,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"University Hospital Foundation; American College of Gastroenterology","keywords":"Inflammatory bowel disease; Intervention (counseling); Reduction (mathematics); Medicine; Disease; Stress reduction; Internal medicine; Gastroenterology; Physical therapy; Nursing; Mathematics","score_opus":0.023808394587964517,"score_gpt":0.24473368918580235,"score_spread":0.22092529459783783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296700750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9704305,0.0009359432,0.003031317,0.01582707,0.00026438315,0.00022360087,0.00014376538,0.000066974855,0.009076492],"genre_scores_gemma":[0.9913838,0.0011519664,0.0020032793,0.0030940375,0.00010058266,0.0002872351,0.000047462247,0.000025654263,0.001905996],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9882181,0.010105166,0.00022310052,0.00024804758,0.000522846,0.0006827553],"domain_scores_gemma":[0.98637575,0.009788069,0.0010035358,0.00022115468,0.0006062005,0.0020052628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00795803,0.00040816315,0.00047514043,0.00044438886,0.0045672976,0.0028023857,0.00083446666,0.002134163,0.00494284],"category_scores_gemma":[0.021165786,0.00035097238,0.0004895579,0.00044916684,0.0028639908,0.002401803,0.0034206684,0.0031071662,0.0005415161],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005360567,0.0008730566,0.010228397,0.00091447344,0.000044890792,0.0039494163,0.91134816,0.0002781707,0.0030602135,0.001819606,0.006473911,0.060473714],"study_design_scores_gemma":[0.00014473744,0.0020888445,0.008106022,0.00081156637,0.00006318765,0.0035294078,0.9227911,0.00058523595,0.0016571132,0.0012533504,0.058874343,0.00009511578],"about_ca_topic_score_codex":0.0011063905,"about_ca_topic_score_gemma":0.0019172061,"teacher_disagreement_score":0.00795803,"about_ca_system_score_codex":0.0017153379,"about_ca_system_score_gemma":0.0021366146,"threshold_uncertainty_score":0.04208654},"labels":[],"label_agreement":null},{"id":"W4310288520","doi":"10.1093/crocol/otac045","title":"Patient-Centered Access to IBD Care: A Qualitative Study","year":2022,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; University of Ottawa; Dalhousie University; University of Toronto; McGill University; University of Calgary; University of Alberta; University of Saskatchewan; Health Sciences Centre","funders":"Canadian Institutes of Health Research","keywords":"Specialty; Medicine; Health care; Thematic analysis; Qualitative research; Family medicine; Focus group; Context (archaeology); Nursing; Geography","score_opus":0.01748449446885665,"score_gpt":0.31906190180490895,"score_spread":0.3015774073360523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310288520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98269355,0.0009764869,0.003991875,0.0048619346,0.00011164233,0.0007094074,0.00042630822,0.000031232656,0.0061975983],"genre_scores_gemma":[0.9927498,0.0011273626,0.0017853031,0.0013342991,0.000027351145,0.0007066638,0.00011357577,0.00002578637,0.0021298311],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.98505265,0.01110366,0.00044608163,0.00065578293,0.0010341969,0.0017076549],"domain_scores_gemma":[0.96718186,0.024394974,0.0017021431,0.0006501868,0.0026681258,0.0034027186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02017006,0.0005612805,0.0009200409,0.0016117862,0.011954833,0.004864656,0.002187599,0.001933259,0.0039070663],"category_scores_gemma":[0.022819493,0.000799736,0.0005918592,0.0022532586,0.009366494,0.004284207,0.0067090597,0.0036904728,0.00039016176],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020743808,0.000030104016,0.0012665692,0.00012147618,0.0000026691457,0.00035083253,0.9953869,0.000021948832,0.00023755591,0.0004910886,0.00029727697,0.0017729192],"study_design_scores_gemma":[0.000004613117,0.000033592056,0.0006180034,0.00015802731,0.0000022507058,0.00014104722,0.9950818,0.000051583353,0.00008707162,0.00015770874,0.003656739,0.000007592171],"about_ca_topic_score_codex":0.027742706,"about_ca_topic_score_gemma":0.04015856,"teacher_disagreement_score":0.027742706,"about_ca_system_score_codex":0.009954335,"about_ca_system_score_gemma":0.012685632,"threshold_uncertainty_score":0.10667074},"labels":[],"label_agreement":null},{"id":"W4311037775","doi":"10.1093/crocol/otac046","title":"Models of Care for Inflammatory Bowel Disease: A National Cross-sectional Survey to Characterize the Landscape of Inflammatory Bowel Disease Care in Canada","year":2022,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of Saskatchewan; Izaak Walton Killam Health Centre; Nova Scotia Health Authority; Dalhousie University","funders":"Crohn's and Colitis Canada","keywords":"Respondent; Medicine; Referral; Collaborative Care; Family medicine; Inflammatory bowel disease; Descriptive statistics; Cross-sectional study; Audit; Disease; Nursing; Primary care; Internal medicine; Pathology","score_opus":0.011468123633281837,"score_gpt":0.242486657677117,"score_spread":0.23101853404383516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311037775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98968554,0.0006227089,0.00017801396,0.00092952343,0.000010246203,0.00012572583,0.005697098,0.000013226722,0.0027378493],"genre_scores_gemma":[0.99725693,0.00040672265,0.0002928491,0.000209412,0.0000038347607,0.000036264726,0.0014262473,0.0000038973194,0.00036390973],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980804,0.00019228959,0.00015344589,0.00021236547,0.0007600104,0.0006014529],"domain_scores_gemma":[0.99511236,0.00031132554,0.0011046379,0.00010895544,0.0020447886,0.0013179857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013037844,0.00022992614,0.0003622116,0.0012775462,0.0028752296,0.0014539452,0.0010972908,0.00038137496,0.0019902939],"category_scores_gemma":[0.0036857668,0.00032594943,0.0004465688,0.004632518,0.00075557694,0.00072998594,0.0012866999,0.00086406467,0.00017502214],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015735155,0.000032238477,0.9955954,0.000043180476,0.000020684754,0.00003033508,0.0009827118,0.000053635238,0.000055338696,0.00006673155,0.0010968909,0.0020071147],"study_design_scores_gemma":[0.0000036233832,0.00001810203,0.9958949,0.000037605485,0.000009610322,0.00002985081,0.0029143263,0.0002562925,0.000027043034,0.000015304791,0.0007868137,0.0000065865024],"about_ca_topic_score_codex":0.9917846,"about_ca_topic_score_gemma":0.9950664,"teacher_disagreement_score":0.035251997,"about_ca_system_score_codex":0.035251997,"about_ca_system_score_gemma":0.045274667,"threshold_uncertainty_score":0.25577235},"labels":[],"label_agreement":null},{"id":"W4319078751","doi":"10.1093/crocol/otad004","title":"Nonalcoholic Fatty Liver Disease Increases Cardiovascular Risk in Inflammatory Bowel Diseases","year":2023,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University Health Centre","funders":"Fonds de Recherche du Québec - Santé; Echosens","keywords":"Nonalcoholic fatty liver disease; Medicine; Transient elastography; Internal medicine; Gastroenterology; Ulcerative colitis; Odds ratio; Inflammatory bowel disease; Population; Fibrosis; Liver disease; Fatty liver; Body mass index; Disease; Liver fibrosis","score_opus":0.014606689658488286,"score_gpt":0.24597749336358624,"score_spread":0.23137080370509794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319078751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856317,0.009999387,0.00069199025,0.00082650204,0.00008732961,0.000024114443,0.0003534381,0.000036353395,0.002349155],"genre_scores_gemma":[0.9970702,0.00168633,0.00043216057,0.00011094452,0.00017776,0.000012942661,0.00023217264,0.000004702314,0.00027274774],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991264,0.00044329299,0.000083206534,0.00012236285,0.00013161727,0.000093172865],"domain_scores_gemma":[0.99561846,0.0011257812,0.0021878195,0.00027981505,0.00022923942,0.00055892626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011769745,0.00045579096,0.00039639056,0.00065163046,0.000388669,0.0006508559,0.00035082953,0.00078837934,0.0036408007],"category_scores_gemma":[0.005052167,0.00041094588,0.0010415298,0.0008116687,0.0002819889,0.00034932437,0.00062408205,0.0011905001,0.00040078623],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002023721,0.00004487713,0.99611676,0.00003816013,0.00013882565,0.00011757331,0.000020401858,0.000042885033,0.00013245018,0.000026208696,0.00011749418,0.003001975],"study_design_scores_gemma":[0.000011370587,0.000059766724,0.99900013,0.000020416079,0.00010603381,0.00035667044,0.000021816097,0.00016644117,0.00002341068,0.00006531794,0.00016642734,0.0000023068258],"about_ca_topic_score_codex":0.001621427,"about_ca_topic_score_gemma":0.0020383883,"teacher_disagreement_score":0.0036408007,"about_ca_system_score_codex":0.00016203408,"about_ca_system_score_gemma":0.00028196926,"threshold_uncertainty_score":0.012179673},"labels":[],"label_agreement":null},{"id":"W4321498772","doi":"10.1093/crocol/otad006","title":"The Real-World Global Use of Patient-Reported Outcomes for the Care of Patients With Inflammatory Bowel Disease","year":2023,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"UCB Pharma; Genentech; Norman Collisson Foundation; Eisai; UK-India Education and Research Initiative; Cilag; Coloplast; Mylan; Celltrion; Wellcome Trust; Leona M. and Harry B. Helmsley Charitable Trust; Janssen Pharmaceuticals; Gilead Sciences; Celgene; Biogen; GlaxoSmithKline; Tillotts Pharma; Amgen; Dr. Falk Pharma; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Inflammatory bowel disease; Medicine; Disease; Intensive care medicine; Internal medicine","score_opus":0.009228585759811274,"score_gpt":0.24883796672918476,"score_spread":0.23960938096937348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321498772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97661304,0.007117,0.0008976946,0.0059021027,0.00013486913,0.000084837855,0.0031408549,0.00004248778,0.0060672043],"genre_scores_gemma":[0.9974891,0.00080698996,0.0006519225,0.000328418,0.00004559865,0.000045725283,0.0005593666,0.000003954234,0.000069009744],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98447174,0.009979645,0.001723507,0.00068567024,0.0026722953,0.0004671967],"domain_scores_gemma":[0.954252,0.014818561,0.022460524,0.0012492292,0.004423575,0.0027960932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01193891,0.00025720696,0.00034375308,0.0017543689,0.00039038926,0.0013409959,0.00050618674,0.0005681869,0.0014220921],"category_scores_gemma":[0.040452857,0.00009507695,0.00054888846,0.0020793234,0.00072886754,0.0015922739,0.0012413503,0.0009535871,0.00021988711],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000076544806,0.00006294969,0.9713803,0.0002598881,0.00014633422,0.00003113188,0.00073798734,0.00013940172,0.00006328146,0.00011904151,0.0013621397,0.025621084],"study_design_scores_gemma":[0.000010823183,0.00027756952,0.99506336,0.0002756052,0.000057633464,0.00020217526,0.0014764441,0.00032334516,0.0000715438,0.00014479492,0.002077363,0.00001925151],"about_ca_topic_score_codex":0.0013447112,"about_ca_topic_score_gemma":0.0023480006,"teacher_disagreement_score":0.01193891,"about_ca_system_score_codex":0.0008303437,"about_ca_system_score_gemma":0.00074185716,"threshold_uncertainty_score":0.063139796},"labels":[],"label_agreement":null},{"id":"W4322155256","doi":"10.1093/crocol/otad012","title":"Crohn’s Disease Patient Experiences and Preferences With Disease Monitoring: An International Qualitative Study","year":2023,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of Saskatchewan","funders":"Genentech; Pfizer; Dr. Falk Pharma; National Institute for Health and Care Research; Leona M. and Harry B. Helmsley Charitable Trust; F. Hoffmann-La Roche; Celltrion; AbbVie; Celgene; Gilead Sciences; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Crohn's disease; Disease; Qualitative research; Medicine; Crohn disease; Intensive care medicine; Internal medicine; Sociology","score_opus":0.023632018261643906,"score_gpt":0.3207818642203414,"score_spread":0.2971498459586975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322155256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99077237,0.00068652054,0.0014969098,0.002562677,0.000048371647,0.00029719042,0.00018768875,0.000012160438,0.003936142],"genre_scores_gemma":[0.9946302,0.0009263601,0.0011622394,0.0011642867,0.000014243987,0.0005361008,0.00007828875,0.000015258978,0.0014730496],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.99034214,0.0071559227,0.00037475588,0.00041289144,0.000531472,0.0011828693],"domain_scores_gemma":[0.9789257,0.015614613,0.0013567472,0.00043723176,0.0016473008,0.0020184238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018913098,0.00043690833,0.00066193717,0.00119588,0.006075881,0.0030276552,0.0010901516,0.001330078,0.0039528417],"category_scores_gemma":[0.02084197,0.00057551556,0.00047117932,0.001444996,0.0062494893,0.0036381655,0.00541885,0.0024877943,0.00031028906],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034172626,0.000049662016,0.0035679399,0.00014859647,0.000004466948,0.0002932529,0.9916794,0.000023673936,0.00027313593,0.00045202175,0.00035270263,0.0031209497],"study_design_scores_gemma":[0.00000593704,0.000058163445,0.0015755043,0.00017695129,0.000004097888,0.00016774947,0.9943551,0.00004060703,0.00008744067,0.00014436712,0.0033737884,0.000010430905],"about_ca_topic_score_codex":0.009438924,"about_ca_topic_score_gemma":0.012965168,"teacher_disagreement_score":0.018913098,"about_ca_system_score_codex":0.0047868295,"about_ca_system_score_gemma":0.005842226,"threshold_uncertainty_score":0.10002327},"labels":[],"label_agreement":null},{"id":"W4322501149","doi":"10.1093/crocol/otad008","title":"Editorial: Pharmacotherapy for Obesity in Persons With Inflammatory Bowel Disease","year":2023,"lang":"en","type":"editorial","venue":"Crohn s & Colitis 360","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Research Manitoba","funders":"","keywords":"Pharmacotherapy; Medicine; Inflammatory bowel disease; Obesity; Disease; Intensive care medicine; Internal medicine","score_opus":0.011515990335038079,"score_gpt":0.286782702715137,"score_spread":0.2752667123800989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322501149","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000026822958,0.0068316273,0.000055962148,0.031233074,0.96034104,0.000024764351,0.000058951646,0.00003594498,0.001391738],"genre_scores_gemma":[0.00024288453,0.0032177926,0.000045466964,0.020543277,0.97220606,0.000023010816,0.00002823232,0.000021520951,0.0036717847],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945531,0.0013709661,0.0007521601,0.0005902638,0.0023322788,0.00040120294],"domain_scores_gemma":[0.976594,0.00973565,0.0023223173,0.0005283269,0.0069695036,0.003850233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007140987,0.00517692,0.006472765,0.005265556,0.0041413656,0.008528535,0.0041461824,0.026549626,0.023584355],"category_scores_gemma":[0.027796261,0.0018495489,0.004639108,0.0024314367,0.002106998,0.004035217,0.0021769158,0.020826658,0.01642539],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007048844,0.000016302793,0.000029140801,0.00027369443,0.000043923817,0.00011409379,0.000006433761,0.000020056621,0.000029985797,0.00008173535,0.9958275,0.003486813],"study_design_scores_gemma":[0.0007059394,0.000112439695,0.00071807706,0.0016779881,0.00044528587,0.0005453506,0.00005795107,0.00039391773,0.00013069282,0.0008745158,0.99429095,0.000047006044],"about_ca_topic_score_codex":0.0023654308,"about_ca_topic_score_gemma":0.007625041,"teacher_disagreement_score":0.026549626,"about_ca_system_score_codex":0.0040503233,"about_ca_system_score_gemma":0.0035191437,"threshold_uncertainty_score":0.078897536},"labels":[],"label_agreement":null},{"id":"W4322730753","doi":"10.1093/crocol/otad009","title":"Efficacy and Safety of Advanced Therapies for Moderately to Severely Active Ulcerative Colitis at Induction and Maintenance: An Indirect Treatment Comparison Using Bayesian Network Meta-analysis","year":2023,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"AbbVie","keywords":"Medicine; Vedolizumab; Golimumab; Internal medicine; Maintenance therapy; Ustekinumab; Ulcerative colitis; Adverse effect; Placebo; Infliximab; Discontinuation; Adalimumab; Tofacitinib; Chemotherapy","score_opus":0.057001298517073674,"score_gpt":0.32664760811582083,"score_spread":0.26964630959874714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322730753","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14307918,0.76810503,0.06672147,0.0040879557,0.0016341971,0.0034570654,0.0074392986,0.00059100956,0.004884803],"genre_scores_gemma":[0.9081606,0.05564918,0.024769643,0.0015089397,0.0005057729,0.0045150793,0.0034920569,0.00011565498,0.001282981],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.953132,0.04033751,0.0021811225,0.0024664332,0.0015160551,0.00036690963],"domain_scores_gemma":[0.95034695,0.04382494,0.0030398727,0.0015066578,0.0008879406,0.00039360626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0429156,0.0033247957,0.013029649,0.0058576916,0.00039766074,0.0029145456,0.002594918,0.002533847,0.0052857897],"category_scores_gemma":[0.06404659,0.0012906215,0.042741656,0.0038225928,0.0007709563,0.0021646607,0.0020149585,0.003401974,0.00032535425],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018589891,0.00015595563,0.0066909664,0.02973819,0.90950346,0.00011760086,0.00008480316,0.01584631,0.00023995995,0.0010315753,0.0007779935,0.01722331],"study_design_scores_gemma":[0.006071018,0.0013721234,0.004809888,0.002955398,0.9580337,0.000111139656,0.000039439514,0.021212572,0.00017609258,0.0038935784,0.0012615334,0.00006352046],"about_ca_topic_score_codex":0.004504756,"about_ca_topic_score_gemma":0.0038196035,"teacher_disagreement_score":0.0429156,"about_ca_system_score_codex":0.0021786192,"about_ca_system_score_gemma":0.0017647017,"threshold_uncertainty_score":0.22696209},"labels":[],"label_agreement":null},{"id":"W4361207010","doi":"10.1093/crocol/otad017","title":"The Impact of Confounders on Symptom–Endoscopic Discordances in Crohn’s Disease","year":2023,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Center for Advancing Translational Sciences; University of California, San Francisco; National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases; Johns Hopkins University; Seres Therapeutics; Crohn's and Colitis Foundation; Pfizer; Genentech; Crohn's and Colitis Foundation of America; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Internal medicine; Medicine; Gastroenterology; Crohn's disease; Diarrhea; Confounding; Abdominal pain; Small intestinal bacterial overgrowth; Disease; Breath test; Severity of illness; Irritable bowel syndrome","score_opus":0.011554231961621158,"score_gpt":0.2909510009977366,"score_spread":0.27939676903611543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361207010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905132,0.00444399,0.0015110319,0.0003763276,0.00013265139,0.0000466371,0.0013935282,0.000020241054,0.0015624677],"genre_scores_gemma":[0.99914765,0.00009290856,0.00021184918,0.000044823522,0.000056304136,0.000019531068,0.000320783,0.0000079359115,0.00009812679],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.97790533,0.013766987,0.002064678,0.0033121866,0.0019700204,0.0009807625],"domain_scores_gemma":[0.937955,0.03523275,0.013902825,0.009735855,0.0015747378,0.0015987974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01505975,0.00058198627,0.00091787043,0.0012062357,0.0009807298,0.0014589285,0.0011582325,0.0011295666,0.0016506378],"category_scores_gemma":[0.03562746,0.00032958444,0.0014717277,0.0023866063,0.0008374102,0.00071416347,0.0010658797,0.0011977633,0.00019615346],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007269639,0.000022376105,0.996698,0.00003903389,0.0007697581,0.0000635958,0.00006998629,0.00009114205,0.00009867088,0.00009269536,0.000091543545,0.0012363419],"study_design_scores_gemma":[0.00002227541,0.00017962912,0.9977894,0.000020344989,0.000401697,0.00020053319,0.00007887247,0.0005549745,0.00016101789,0.00021650987,0.00036575677,0.000008999126],"about_ca_topic_score_codex":0.0028897445,"about_ca_topic_score_gemma":0.0014508277,"teacher_disagreement_score":0.01505975,"about_ca_system_score_codex":0.00042727674,"about_ca_system_score_gemma":0.00048042266,"threshold_uncertainty_score":0.07964456},"labels":[],"label_agreement":null},{"id":"W4384281358","doi":"10.1093/crocol/otad033","title":"Economic and Clinical Burden of Herpes Zoster Among Patients With Inflammatory Bowel Disease in the United States","year":2023,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"GlaxoSmithKline Biologicals; American College of Gastroenterology","keywords":"Medicine; Inflammatory bowel disease; Confidence interval; Emergency department; Incidence (geometry); Ulcerative colitis; Health care; Propensity score matching; Rate ratio; Internal medicine; Disease","score_opus":0.013223371049524778,"score_gpt":0.282289147321991,"score_spread":0.26906577627246625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384281358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945598,0.0021743646,0.00010555527,0.0005566405,0.00002095148,0.000014744779,0.0019127786,0.0000034557468,0.0006515938],"genre_scores_gemma":[0.99836546,0.0005561041,0.00007631109,0.000085663625,0.000025720468,0.000007935525,0.00082197174,6.567594e-7,0.0000600797],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987116,0.0006748883,0.00017191794,0.00011406077,0.00017293879,0.00015462445],"domain_scores_gemma":[0.99685884,0.0004953355,0.0021678035,0.00007410865,0.0001462823,0.00025769108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094235333,0.00021916708,0.00029570467,0.0010338239,0.0002739961,0.00092971354,0.00026357058,0.00032203653,0.0013212633],"category_scores_gemma":[0.0045111417,0.00018353818,0.00075525226,0.0016205219,0.00028786584,0.00046694552,0.0007706731,0.00048651363,0.000087267676],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060541166,0.00002922207,0.99702317,0.000031685668,0.00019882023,0.0000495048,0.000022638616,0.00042687103,0.000019931123,0.00007722404,0.00039522588,0.0016652744],"study_design_scores_gemma":[0.00001747104,0.000053681782,0.99703634,0.00005033841,0.00010594271,0.00016335018,0.00020669238,0.0018376686,0.000022478875,0.00012026024,0.00038008645,0.0000057099533],"about_ca_topic_score_codex":0.017953452,"about_ca_topic_score_gemma":0.01586452,"teacher_disagreement_score":0.017953452,"about_ca_system_score_codex":0.0010583502,"about_ca_system_score_gemma":0.0006051908,"threshold_uncertainty_score":0.035697937},"labels":[],"label_agreement":null},{"id":"W4385618950","doi":"10.1093/crocol/otad043","title":"Integrating Intestinal Ultrasound into an Inflammatory Bowel Disease Practice: How to Get Started","year":2023,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Microscopic Colitis","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Inflammatory bowel disease; Medicine; Disease; Inflammatory Bowel Diseases; Intensive care medicine; Family medicine; Pathology","score_opus":0.016154307590608468,"score_gpt":0.31417136503622467,"score_spread":0.2980170574456162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385618950","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03048894,0.007782008,0.045944642,0.8490598,0.0070378412,0.0030104634,0.00014448914,0.0021504124,0.054381464],"genre_scores_gemma":[0.20714577,0.027731227,0.5525876,0.1855971,0.004131506,0.006356663,0.00043757004,0.00066264195,0.015349911],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9534386,0.02909501,0.0033671204,0.0016837037,0.008227945,0.0041875406],"domain_scores_gemma":[0.9419173,0.01590496,0.0035459818,0.0026951397,0.008558519,0.0273782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03841205,0.0014542214,0.0013293099,0.0026731114,0.009507179,0.013497877,0.003920164,0.012460779,0.011182856],"category_scores_gemma":[0.07281297,0.0014405705,0.001858105,0.0015078189,0.009142183,0.018131921,0.017866828,0.01578316,0.008031182],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016099818,0.0045976643,0.021775607,0.003632727,0.00010147222,0.002857116,0.056891732,0.0010845134,0.0028115143,0.017750662,0.19070186,0.69763404],"study_design_scores_gemma":[0.0006044723,0.0043578534,0.043055665,0.03023245,0.00024988662,0.0048938915,0.17825435,0.0023792866,0.0025805542,0.0815205,0.6509291,0.0009419882],"about_ca_topic_score_codex":0.008528325,"about_ca_topic_score_gemma":0.020221716,"teacher_disagreement_score":0.03841205,"about_ca_system_score_codex":0.00618275,"about_ca_system_score_gemma":0.043903135,"threshold_uncertainty_score":0.20314479},"labels":[],"label_agreement":null},{"id":"W4386008142","doi":"10.1093/crocol/otad034","title":"Practical Primer Addressing Real-World Use Scenarios of Subcutaneous Vedolizumab in Ulcerative Colitis and Crohn’s Disease: Post Hoc Analyses of VISIBLE Studies","year":2023,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Takeda Pharmaceuticals U.S.A.","keywords":"Vedolizumab; Medicine; Ulcerative colitis; Dosing; Internal medicine; Post-hoc analysis; Crohn's disease; Gastroenterology; Clinical trial; Maintenance therapy; Disease; Chemotherapy","score_opus":0.07314988302568722,"score_gpt":0.38284115858999007,"score_spread":0.30969127556430287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386008142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.54143137,0.005154592,0.33987352,0.0063659633,0.0046977913,0.06934209,0.011109507,0.0014842838,0.020540802],"genre_scores_gemma":[0.7591025,0.0005066767,0.17349368,0.0035153918,0.00061333505,0.056266125,0.0032327021,0.00035675603,0.0029127635],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.6431903,0.32000968,0.009611519,0.010508422,0.0143377315,0.0023423166],"domain_scores_gemma":[0.37067783,0.5543336,0.028507298,0.027499104,0.01729429,0.0016877657],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.2523202,0.0022805582,0.0022533166,0.0027792435,0.001319822,0.0031432183,0.0025733418,0.0025435647,0.0086348625],"category_scores_gemma":[0.39563382,0.000901741,0.0077517913,0.002447904,0.0028972959,0.0029675388,0.0029463195,0.0029772413,0.0008174711],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11168856,0.0077966154,0.31637833,0.01312554,0.07080063,0.00428931,0.007746026,0.042091746,0.021571893,0.023994936,0.073605046,0.30691132],"study_design_scores_gemma":[0.02246686,0.16285147,0.25783738,0.0030981877,0.039417636,0.002858255,0.007754009,0.16949078,0.03381269,0.030062148,0.26949054,0.0008601129],"about_ca_topic_score_codex":0.0006829427,"about_ca_topic_score_gemma":0.0011672092,"teacher_disagreement_score":0.2523202,"about_ca_system_score_codex":0.0014923868,"about_ca_system_score_gemma":0.0030525734,"threshold_uncertainty_score":0.9220223},"labels":[],"label_agreement":null},{"id":"W4386260834","doi":"10.1093/crocol/otad045","title":"Persistence and Dose Escalation During Maintenance Phase and Use of Nonbiologic Medications Among Patients With Ulcerative Colitis Initiated on Ustekinumab in the United States","year":2023,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"Janssen Scientific Affairs","keywords":"Ustekinumab; Medicine; Odds ratio; Maintenance therapy; Confidence interval; Internal medicine; Ulcerative colitis; Corticosteroid; Prednisone; Disease; Chemotherapy","score_opus":0.0204497148688626,"score_gpt":0.2542550695092782,"score_spread":0.23380535464041557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386260834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99914455,0.00024747086,0.000042862153,0.000021806103,0.0000016129409,0.0000039036836,0.00041220093,0.0000021810665,0.00012321852],"genre_scores_gemma":[0.9994549,0.00005225162,0.000030245736,0.000014330454,0.000004115835,0.00000361312,0.0003889886,9.573741e-7,0.000050503608],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990682,0.0002465681,0.0001596369,0.00022917843,0.00016077547,0.00013566439],"domain_scores_gemma":[0.99440235,0.00094927516,0.0037740946,0.0002255964,0.00020234252,0.00044628448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012019817,0.00019183567,0.00032335633,0.0008701187,0.00026738388,0.0007603699,0.0003448042,0.00037077465,0.0014929945],"category_scores_gemma":[0.0029114624,0.00020634336,0.0006811935,0.0010494316,0.00022828433,0.00054956716,0.00047611995,0.00056822185,0.00017347581],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016603315,0.000022923316,0.99905187,0.0000044097796,0.00003863478,0.000012744786,0.000019630457,0.00003269324,0.000049532824,0.000004487908,0.000032730084,0.000564314],"study_design_scores_gemma":[0.000008396367,0.00011888383,0.9991462,0.000006814412,0.000032130316,0.00010379017,0.00007403287,0.00036549615,0.000057227488,0.000009860004,0.00007467503,0.0000024244944],"about_ca_topic_score_codex":0.0041817734,"about_ca_topic_score_gemma":0.00440977,"teacher_disagreement_score":0.0041817734,"about_ca_system_score_codex":0.00038264194,"about_ca_system_score_gemma":0.00034310255,"threshold_uncertainty_score":0.008314848},"labels":[],"label_agreement":null},{"id":"W4386950391","doi":"10.1093/crocol/otad050","title":"Bedside Intestinal Ultrasound Performed in an Inflammatory Bowel Disease Urgent Assessment Clinic Improves Clinical Decision-Making and Resource Utilization","year":2023,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Gastroenterological Society of Australia; Celltrion; Australian Government; Celltrion Healthcare; Amgen; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Calprotectin; Inflammatory bowel disease; Endoscopy; Sigmoidoscopy; Internal medicine; Disease; Observational study; Intensive care medicine; Colonoscopy; Colorectal cancer","score_opus":0.025405531874836927,"score_gpt":0.35444731117900097,"score_spread":0.32904177930416406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386950391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99635065,0.0005569168,0.00029505577,0.0005490673,0.000021963358,0.00003671778,0.0003023393,0.000020446347,0.0018667877],"genre_scores_gemma":[0.9990736,0.00010163436,0.00048066006,0.00009102906,0.000030062005,0.000012132533,0.00015755511,0.0000018154569,0.000051492476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99633384,0.0021772296,0.00033132383,0.0004355078,0.0004017197,0.00032029324],"domain_scores_gemma":[0.9929086,0.0018792847,0.0034481795,0.00020362278,0.00042782867,0.0011324149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015150057,0.0002801514,0.0004291293,0.00078215945,0.00041058546,0.0011165295,0.0003777715,0.00038600637,0.00301907],"category_scores_gemma":[0.008221357,0.00021267311,0.00033968,0.00087318337,0.00030437147,0.0005287492,0.00087179587,0.000660955,0.00029003914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015556053,0.00024380273,0.99053395,0.00004108678,0.000046922123,0.000080948455,0.00007844642,0.00011143192,0.00017782552,0.00001988823,0.0005667799,0.007943364],"study_design_scores_gemma":[0.00005401643,0.00057169364,0.99595153,0.000094223666,0.000044913868,0.00037443542,0.00064136717,0.0015969374,0.00017959604,0.00008606427,0.0003946776,0.000010612938],"about_ca_topic_score_codex":0.0027064867,"about_ca_topic_score_gemma":0.0043590777,"teacher_disagreement_score":0.00301907,"about_ca_system_score_codex":0.00056410534,"about_ca_system_score_gemma":0.0009787024,"threshold_uncertainty_score":0.010099769},"labels":[],"label_agreement":null},{"id":"W4388184549","doi":"10.1093/crocol/otad066","title":"Thiopurine exposure during pregnancy is not associated with anemia in infants born to mothers with IBD","year":2023,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Calgary","funders":"","keywords":"Thiopurine methyltransferase; Pregnancy; Medicine; Anemia; Obstetrics; Pediatrics; Inflammatory bowel disease; Internal medicine; Biology; Disease; Genetics","score_opus":0.01706048207461893,"score_gpt":0.27113676160345945,"score_spread":0.25407627952884054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388184549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991365,0.00037388905,0.000046462555,0.000035189372,0.000009447222,0.0000033150222,0.000100530975,0.000001998973,0.00029275203],"genre_scores_gemma":[0.99955505,0.00018122917,0.000039082926,0.000016895468,0.000008363728,0.000005158973,0.000080158476,0.0000013486701,0.00011271033],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99947006,0.00015500256,0.000057733545,0.0001232569,0.00009419949,0.00009966191],"domain_scores_gemma":[0.9977386,0.00060977583,0.0010575881,0.00015037438,0.00014442799,0.0002992817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005147959,0.00026203212,0.00034952888,0.00056774926,0.0003723403,0.0005988517,0.00037173595,0.00048715496,0.0027164319],"category_scores_gemma":[0.004316106,0.0002808727,0.00046827938,0.0006208417,0.00025870992,0.00027170219,0.00039268512,0.00052419375,0.0002473977],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024313251,0.00002795353,0.9981462,0.000008794149,0.000027826234,0.00028961553,0.000091287104,0.0000059918343,0.00020076089,0.000009053269,0.00003860458,0.00091097254],"study_design_scores_gemma":[0.0000109768425,0.00033059195,0.9974921,0.000029532828,0.00007297633,0.0013074842,0.00036380987,0.00010137114,0.00010685188,0.00002165146,0.00015875082,0.0000038750723],"about_ca_topic_score_codex":0.0040709437,"about_ca_topic_score_gemma":0.0018459504,"teacher_disagreement_score":0.0040709437,"about_ca_system_score_codex":0.00019591702,"about_ca_system_score_gemma":0.00032298785,"threshold_uncertainty_score":0.009087324},"labels":[],"label_agreement":null},{"id":"W4388516135","doi":"10.1093/crocol/otad070","title":"Mirikizumab Improves Quality of Life in Patients With Moderately-to-Severely Active Ulcerative Colitis: Results From the Phase 3 LUCENT-1 Induction and LUCENT-2 Maintenance Studies","year":2023,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Ulcerative colitis; Phase (matter); Colitis; Medicine; Internal medicine; Surgery; Physics; Disease","score_opus":0.025577921023351657,"score_gpt":0.2965194893346426,"score_spread":0.27094156831129096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388516135","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98280543,0.015172636,0.00022937564,0.00031348522,0.000052278985,0.00031691836,0.0003540281,0.000032387416,0.0007234098],"genre_scores_gemma":[0.9957806,0.0023654473,0.000563492,0.0003389806,0.0000793281,0.00015866217,0.0004806138,0.00000464675,0.00022830057],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.999181,0.00052825717,0.000075449236,0.00007213898,0.000076903234,0.00006627286],"domain_scores_gemma":[0.9986951,0.00037115588,0.0004501481,0.00008854251,0.00010096436,0.0002941223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002795703,0.0007007362,0.0014480953,0.00024880754,0.00023811725,0.0004959232,0.00045026193,0.00049979007,0.0013073768],"category_scores_gemma":[0.0014429793,0.00023348932,0.0018236908,0.00031929032,0.00039936326,0.00049046334,0.00025847275,0.0009334179,0.00019317174],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.69930726,0.012407273,0.04394269,0.0028852804,0.0071335,0.00019732417,0.0002724454,0.00076836353,0.040023882,0.00009247526,0.0024278986,0.19054164],"study_design_scores_gemma":[0.25580874,0.32875878,0.39861476,0.0002946021,0.005793958,0.00047873924,0.00015078529,0.001264788,0.00482671,0.00015220235,0.0037735456,0.00008230638],"about_ca_topic_score_codex":0.0003878808,"about_ca_topic_score_gemma":0.0012417365,"teacher_disagreement_score":0.002795703,"about_ca_system_score_codex":0.00036167348,"about_ca_system_score_gemma":0.00042931343,"threshold_uncertainty_score":0.01478523},"labels":[],"label_agreement":null},{"id":"W4390640897","doi":"10.1093/crocol/otae001","title":"Association of Bowel Urgency With Quality-of-Life Measures in Patients With Moderately-to-Severely Active Ulcerative Colitis: Results From Phase 3 LUCENT-1 (Induction) and LUCENT-2 (Maintenance) Studies","year":2024,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Eli Lilly and Company","keywords":"Medicine; Quality of life (healthcare); Placebo; Internal medicine; Ulcerative colitis; Physical therapy; Gastroenterology; Disease","score_opus":0.02051848259193821,"score_gpt":0.2878773408196919,"score_spread":0.2673588582277537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390640897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841883,0.013846886,0.00019228715,0.00019732374,0.00002764606,0.00014394843,0.0008934286,0.000010570963,0.0004995894],"genre_scores_gemma":[0.9972516,0.0010831179,0.000316621,0.00017358188,0.00005140872,0.00008977869,0.0009173282,0.0000023780535,0.00011428006],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99742186,0.0016167496,0.00027339405,0.00025286744,0.00028942968,0.00014578596],"domain_scores_gemma":[0.9935998,0.0020822997,0.0028186454,0.00030795208,0.00053756736,0.00065381057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0066152327,0.00054847583,0.0012480519,0.00042379042,0.00025135593,0.0006890279,0.00049001427,0.0006119317,0.00095657184],"category_scores_gemma":[0.0041332203,0.00020514063,0.0021445693,0.00060006895,0.00038081422,0.0005449163,0.00044958427,0.0007747809,0.00012197577],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18450804,0.0022108518,0.73594177,0.0020499115,0.0139141735,0.00008605211,0.0001601115,0.0005774299,0.003907491,0.000059430367,0.0011850398,0.055399697],"study_design_scores_gemma":[0.011924753,0.027150972,0.9552886,0.00012924348,0.0033149011,0.00013592181,0.000067542955,0.0004848256,0.0006013743,0.00004317558,0.0008216376,0.00003700519],"about_ca_topic_score_codex":0.00054923305,"about_ca_topic_score_gemma":0.0013446376,"teacher_disagreement_score":0.0066152327,"about_ca_system_score_codex":0.00034877032,"about_ca_system_score_gemma":0.0002994687,"threshold_uncertainty_score":0.034985125},"labels":[],"label_agreement":null},{"id":"W4391463039","doi":"10.1093/crocol/otae006","title":"Normal Infant Immunologic Assessment and Uneventful Live Rotavirus Vaccination Despite Continuous Tofacitinib Exposure In Utero and During Breastfeeding","year":2024,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research; New South Wales Government; Crohn's and Colitis Canada; Pfizer; Alberta Children's Hospital Research Institute; Eli Lilly and Company","keywords":"Medicine; Tofacitinib; Breastfeeding; Infliximab; Pregnancy; Inflammatory bowel disease; Pediatrics; Ulcerative colitis; Vedolizumab; Vaccination; Disease; Obstetrics; Immunology; Internal medicine","score_opus":0.011582987073521902,"score_gpt":0.29568045543708943,"score_spread":0.28409746836356753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391463039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97478616,0.0064342534,0.0030439703,0.0029448934,0.0002383951,0.00010934496,0.00030512756,0.0001635328,0.011974343],"genre_scores_gemma":[0.9946084,0.0022823731,0.0011465916,0.000597434,0.000072041104,0.000027149565,0.00013152765,0.000017660781,0.0011167233],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9996125,0.00007087812,0.000034052613,0.00008457459,0.00008339474,0.000114591036],"domain_scores_gemma":[0.9996369,0.00007147843,0.00009583525,0.000020377103,0.000053586664,0.00012177771],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028006488,0.00050248904,0.0005251977,0.000730978,0.0005995453,0.00036669004,0.00037929107,0.0009263494,0.0006200789],"category_scores_gemma":[0.0016556486,0.00024314845,0.00042158432,0.0002637498,0.00046827542,0.00044187676,0.00042751734,0.0018122464,0.00020698951],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022815984,0.00010923743,0.074034646,0.00007918814,0.000024328183,0.90095335,0.00082045083,0.00024599244,0.007250563,0.0003177948,0.0007628529,0.015173437],"study_design_scores_gemma":[0.000013536787,0.0006967397,0.094805524,0.00012396829,0.000044362354,0.89506733,0.0005594797,0.0006060138,0.0035541875,0.00029011408,0.0042020143,0.00003665279],"about_ca_topic_score_codex":0.0027810002,"about_ca_topic_score_gemma":0.0022788413,"teacher_disagreement_score":0.0027810002,"about_ca_system_score_codex":0.00070444157,"about_ca_system_score_gemma":0.00055611884,"threshold_uncertainty_score":0.0055295825},"labels":[],"label_agreement":null},{"id":"W4392004938","doi":"10.1093/crocol/otae009","title":"Dietary Magnesium Intake Is Inversely Associated With Ulcerative Colitis: A Case–Control Study","year":2024,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Magnesium in Health and Disease","field":"Nursing","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Tehran University of Medical Sciences and Health Services","keywords":"Ulcerative colitis; Magnesium; Gastroenterology; Medicine; Internal medicine; Food science; Environmental health; Chemistry; Disease","score_opus":0.0231030594569894,"score_gpt":0.28683948561900935,"score_spread":0.26373642616202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392004938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984263,0.00090435345,0.0001784379,0.00004022205,0.00001275319,0.000027693686,0.0001171448,0.0000048956344,0.00028821125],"genre_scores_gemma":[0.9992324,0.000267246,0.00016904656,0.000039796018,0.000026645872,0.000019813659,0.0001434659,0.000002289895,0.00009917729],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99875903,0.00043657993,0.00015466394,0.00036535953,0.00018925656,0.00009512616],"domain_scores_gemma":[0.9983296,0.00046897214,0.0005953704,0.0002467258,0.0001504913,0.00020874587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013311368,0.00046571446,0.0007742174,0.0009911776,0.0007081763,0.00092366803,0.0005856739,0.00095071277,0.0018202844],"category_scores_gemma":[0.0033735153,0.0007481039,0.00065864786,0.0017628847,0.00054530025,0.0004326686,0.00039292497,0.00065377756,0.00020445212],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094281306,0.00027471568,0.99576795,0.000051973344,0.0005764694,0.0003553007,0.00014940235,0.000022635573,0.0005403966,0.00003177145,0.00011257666,0.0011740482],"study_design_scores_gemma":[0.00012875463,0.00055031397,0.99744225,0.000018358096,0.00042047398,0.0008253053,0.00008672475,0.00017307648,0.00005667638,0.000029784067,0.00026118217,0.000007067269],"about_ca_topic_score_codex":0.0044106264,"about_ca_topic_score_gemma":0.0037426066,"teacher_disagreement_score":0.0044106264,"about_ca_system_score_codex":0.00030351954,"about_ca_system_score_gemma":0.0002503075,"threshold_uncertainty_score":0.008769929},"labels":[],"label_agreement":null},{"id":"W4392886292","doi":"10.1093/crocol/otae019","title":"Toward Patient Centricity: Why Do Patients With Inflammatory Bowel Disease Participate in Pharmaceutical Clinical Trials? A Mixed-Methods Exploration of Study Participants","year":2024,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Clinical trial; Placebo; Inflammatory bowel disease; Inclusion (mineral); Family medicine; Outreach; Patient recruitment; Disease; Alternative medicine; Physical therapy; Internal medicine; Psychology; Pathology","score_opus":0.6111138710781772,"score_gpt":0.6296515015508516,"score_spread":0.018537630472674427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392886292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96101946,0.0055245226,0.01472958,0.012168389,0.00013979388,0.0035143287,0.00028444393,0.000028388607,0.0025912037],"genre_scores_gemma":[0.97705895,0.0012561048,0.011364851,0.005098216,0.00005372058,0.004775903,0.00010169691,0.000020438743,0.00027005048],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.6532384,0.3147367,0.013092331,0.005110609,0.010464654,0.003357249],"domain_scores_gemma":[0.72189665,0.23005445,0.029812405,0.006934996,0.0081364885,0.003165016],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.2530024,0.00057832565,0.0010570397,0.002467605,0.0040170983,0.007713287,0.0025440424,0.0025086699,0.0018821134],"category_scores_gemma":[0.25566235,0.0010314387,0.0011776782,0.0023412448,0.0052960864,0.0068686195,0.0059028286,0.002216028,0.0002638474],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006152002,0.0005219361,0.13694206,0.0032753088,0.00043356602,0.00055474916,0.790668,0.00015497216,0.0008277755,0.00474062,0.0015178072,0.05974801],"study_design_scores_gemma":[0.00029772348,0.0013311674,0.049345773,0.0060370336,0.00031810263,0.0010783381,0.91693896,0.0021059222,0.000895882,0.007864913,0.013649683,0.00013647554],"about_ca_topic_score_codex":0.0025019953,"about_ca_topic_score_gemma":0.004281136,"teacher_disagreement_score":0.7469976,"about_ca_system_score_codex":0.0044000316,"about_ca_system_score_gemma":0.008495057,"threshold_uncertainty_score":0.921181},"labels":[],"label_agreement":null},{"id":"W4393106191","doi":"10.1093/crocol/otae015","title":"Evaluation of Factors Contributing to Diagnosis of Crohn’s Disease in the Face of Increasing Trend in Pakistan","year":2024,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Disease; Diarrhea; Crohn's disease; Abdominal pain; Medical record; Inflammatory bowel disease; Radiological weapon; Health care; Retrospective cohort study; Developing country; Limited resources; Internal medicine; Pediatrics; Surgery","score_opus":0.019269306795005953,"score_gpt":0.3216546604060501,"score_spread":0.3023853536110442,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393106191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997874,0.0005907081,0.000056591467,0.00034320483,0.000018362069,0.000012842074,0.00021461137,0.000002057948,0.00088768906],"genre_scores_gemma":[0.9992932,0.00036173136,0.000079431535,0.000039982875,0.000019645744,0.0000042971005,0.00013023322,6.7510456e-7,0.00007076945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994579,0.0001372002,0.00007868615,0.00006747807,0.00010611822,0.00015268948],"domain_scores_gemma":[0.99784064,0.00046069612,0.0009975536,0.00004214096,0.00031993104,0.00033898067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005884307,0.00019711265,0.00024977967,0.0008133193,0.0007878938,0.0007598426,0.00025160407,0.00037852564,0.002015765],"category_scores_gemma":[0.0035127734,0.0001737208,0.00021439984,0.0010257507,0.0003240337,0.00064362056,0.00038682728,0.0006256013,0.00021270009],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023109162,0.0000147970295,0.99808514,0.000015240901,0.0000038716935,0.00036285276,0.00011967405,0.0000120269515,0.000032700595,0.000011111831,0.0001072515,0.0012122049],"study_design_scores_gemma":[0.0000031508619,0.000087937384,0.9939917,0.000045753593,0.000016681703,0.0020026276,0.0030583052,0.0001540367,0.00005707425,0.00003507267,0.00054114737,0.0000064608835],"about_ca_topic_score_codex":0.008893469,"about_ca_topic_score_gemma":0.008965845,"teacher_disagreement_score":0.008893469,"about_ca_system_score_codex":0.00057762826,"about_ca_system_score_gemma":0.0010672127,"threshold_uncertainty_score":0.017683387},"labels":[],"label_agreement":null},{"id":"W4396771004","doi":"10.1093/crocol/otae031","title":"Cannabis Use in Patients With Inflammatory Bowel Disease Following Legalization of Cannabis in Canada","year":2024,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"","keywords":"Legalization; Cannabis; Inflammatory bowel disease; Medicine; Disease; Psychiatry; Traditional medicine; Internal medicine; Gastroenterology","score_opus":0.006999479675122657,"score_gpt":0.2359943108272297,"score_spread":0.22899483115210703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396771004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99172676,0.0014804957,0.000045407793,0.00097255874,0.000026892994,0.000066620625,0.0025922277,0.000006131339,0.003082912],"genre_scores_gemma":[0.9973412,0.0010121223,0.00007607745,0.00030701462,0.000012655123,0.000013498637,0.00076111406,0.0000022508566,0.00047406802],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993642,0.000041529736,0.000042444015,0.000074617696,0.00022333057,0.00025384236],"domain_scores_gemma":[0.9983619,0.000103252954,0.00053668604,0.000028610633,0.00048903865,0.00048058204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032450794,0.00015754739,0.00030471146,0.0008570036,0.0021333455,0.0007864232,0.0005796147,0.00035329274,0.0027446395],"category_scores_gemma":[0.001662568,0.00018933664,0.0004181299,0.0026086026,0.0004934408,0.00027736113,0.0006998138,0.0008504952,0.00019001286],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005527424,0.000027206248,0.9953798,0.00006174761,0.000019015477,0.00023390853,0.00048027537,0.000020368321,0.00011572909,0.000033969238,0.00068431505,0.0028883945],"study_design_scores_gemma":[0.0000075672456,0.00002005548,0.99787176,0.000057794965,0.000017449396,0.00020154829,0.0009374417,0.000077679484,0.000029218367,0.000017325201,0.0007548319,0.000007279001],"about_ca_topic_score_codex":0.95294845,"about_ca_topic_score_gemma":0.9708018,"teacher_disagreement_score":0.04705155,"about_ca_system_score_codex":0.01123625,"about_ca_system_score_gemma":0.016544625,"threshold_uncertainty_score":0.09465724},"labels":[],"label_agreement":null},{"id":"W4399670425","doi":"10.1093/crocol/otae038","title":"Differences Between the 2016 and 2022 Food and Drug Administration Guidance—Implications for Design and Interpretation of Clinical Trials in Ulcerative Colitis","year":2024,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Calgary","funders":"","keywords":"Ulcerative colitis; Interpretation (philosophy); Medicine; Clinical trial; Medical physics; Intensive care medicine; Internal medicine; Computer science; Disease","score_opus":0.061786576523041675,"score_gpt":0.3808542807149654,"score_spread":0.31906770419192376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399670425","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005531298,0.10104642,0.045854706,0.7368836,0.074751146,0.007379855,0.002665844,0.0009521799,0.024934944],"genre_scores_gemma":[0.07102545,0.019574566,0.22211446,0.62304884,0.03166344,0.024453904,0.0020047333,0.0010980539,0.0050165793],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.09564653,0.69506943,0.11047629,0.011846615,0.08281752,0.004143577],"domain_scores_gemma":[0.04775515,0.74477977,0.052252036,0.03214087,0.11613789,0.006934329],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.7955655,0.002445447,0.009752226,0.009321283,0.004100344,0.031637594,0.0118123405,0.039466847,0.004600905],"category_scores_gemma":[0.9062293,0.003795732,0.012352349,0.010489255,0.01731016,0.014226418,0.007874184,0.033113785,0.0039605107],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0098975515,0.00065892027,0.006308609,0.029989585,0.0059019136,0.0007068525,0.0070848,0.004857065,0.001954821,0.094808266,0.46141177,0.37642],"study_design_scores_gemma":[0.007998562,0.0032081995,0.015587423,0.108354285,0.005272263,0.00089114957,0.0020965736,0.006506553,0.002085675,0.13831654,0.70828915,0.0013937844],"about_ca_topic_score_codex":0.0080172485,"about_ca_topic_score_gemma":0.009477916,"teacher_disagreement_score":0.20443451,"about_ca_system_score_codex":0.029728677,"about_ca_system_score_gemma":0.062001534,"threshold_uncertainty_score":0.25210422},"labels":[],"label_agreement":null},{"id":"W4403360578","doi":"10.1093/crocol/otae056","title":"Interventions for Adjunctive Care in Patients With Inflammatory Bowel Disease and Permanent Ileostomy: A Systematic Review","year":2024,"lang":"en","type":"review","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; McMaster University; Population Health Research Institute; Lawson Health Research Institute; Western University","funders":"Leona M. and Harry B. Helmsley Charitable Trust","keywords":"Medicine; Inflammatory bowel disease; Psychological intervention; Adjunctive treatment; Ileostomy; Intensive care medicine; Disease; General surgery; Surgery; Internal medicine; Psychiatry","score_opus":0.010823146638998781,"score_gpt":0.28515540106879184,"score_spread":0.27433225442979303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403360578","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013206278,0.9978763,0.0000613879,0.00013164456,0.000055834225,0.00023236588,0.00012958184,0.000005500952,0.00018677587],"genre_scores_gemma":[0.020085774,0.97799325,0.00062958174,0.00038119496,0.00006510515,0.000607925,0.00014555526,0.0000030751662,0.00008855795],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99567586,0.0018639184,0.001377797,0.0002657557,0.00067293824,0.00014363842],"domain_scores_gemma":[0.98293704,0.012478271,0.003255881,0.00015816868,0.0009089106,0.00026177525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004912801,0.0011321645,0.0077459174,0.006047218,0.00048990425,0.0017983963,0.0015522926,0.0016725718,0.004336741],"category_scores_gemma":[0.018963967,0.000752542,0.006039012,0.0065487977,0.00070660963,0.0013694558,0.001053367,0.0011337602,0.0002087487],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038826696,0.000036311252,0.00056689937,0.9526629,0.007226061,0.00008531293,0.00012979003,0.00006434927,0.00007156949,0.00010136632,0.00075443264,0.037912708],"study_design_scores_gemma":[0.0012678809,0.00060870877,0.0066271448,0.88780016,0.08703943,0.00048768014,0.0003877875,0.00013975981,0.0001764793,0.00021108476,0.015210313,0.00004354157],"about_ca_topic_score_codex":0.0065175975,"about_ca_topic_score_gemma":0.018340504,"teacher_disagreement_score":0.0077459174,"about_ca_system_score_codex":0.002717525,"about_ca_system_score_gemma":0.006853112,"threshold_uncertainty_score":0.025981724},"labels":[],"label_agreement":null},{"id":"W4404614292","doi":"10.1093/crocol/otae052","title":"Predictive Model for Outcomes in Inflammatory Bowel Disease Patients Receiving Maintenance Infliximab Therapy","year":2024,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Infliximab; Inflammatory bowel disease; Medicine; Maintenance therapy; Internal medicine; Disease; Intensive care medicine; Chemotherapy","score_opus":0.00875503567726365,"score_gpt":0.24893237758128067,"score_spread":0.24017734190401702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404614292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94114804,0.0012361226,0.049181707,0.0014769955,0.00019682139,0.00020278199,0.0030253641,0.0006436831,0.002888519],"genre_scores_gemma":[0.99373686,0.00013215315,0.0040858276,0.000057120647,0.00005678033,0.00006979925,0.0012367364,0.000024409017,0.0006003484],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99879277,0.0006229409,0.00008310818,0.00016832113,0.00018634294,0.00014652582],"domain_scores_gemma":[0.9940229,0.0040835966,0.00071426894,0.00021848874,0.00068438856,0.00027624518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034854012,0.0011420904,0.0008998257,0.0020219802,0.00031714063,0.001474937,0.0009833795,0.00056719215,0.0029673188],"category_scores_gemma":[0.0093403775,0.0002872753,0.001352834,0.0006586855,0.00026939594,0.00042967987,0.0007637438,0.0009807883,0.00064394856],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016213965,0.00038636636,0.8578485,0.000089662164,0.0008532364,0.00044258955,0.000087412154,0.10163093,0.00043611563,0.0007771133,0.002984636,0.032841995],"study_design_scores_gemma":[0.00009400925,0.0003650929,0.08278231,0.000072289775,0.00042512149,0.0004373924,0.00008637213,0.91159505,0.00037720686,0.002408142,0.0013260611,0.000030901872],"about_ca_topic_score_codex":0.005948545,"about_ca_topic_score_gemma":0.0032944384,"teacher_disagreement_score":0.005948545,"about_ca_system_score_codex":0.00067927036,"about_ca_system_score_gemma":0.0010954312,"threshold_uncertainty_score":0.018432736},"labels":[],"label_agreement":null},{"id":"W4404985157","doi":"10.1093/crocol/otae071","title":"Association Between Serum Ustekinumab Concentrations and Endoscopic Disease Activity in Moderate-to-Severe Crohn’s Disease Patients","year":2024,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McGill University Health Centre","funders":"McGill University Health Centre; McGill University","keywords":"Ustekinumab; Medicine; Internal medicine; Gastroenterology; Crohn's disease; Disease; Infliximab","score_opus":0.007755674367782097,"score_gpt":0.24286549455495035,"score_spread":0.23510982018716825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404985157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99956626,0.00018464112,0.000031747437,0.000019819883,0.0000026994333,0.000002819778,0.000042550404,0.0000013943186,0.00014803783],"genre_scores_gemma":[0.999813,0.000032886855,0.000043144115,0.000011396022,0.0000065413146,0.000002073682,0.000061282975,4.968107e-7,0.000029222407],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995958,0.00014115634,0.000069048474,0.00006740833,0.00006952515,0.000057215686],"domain_scores_gemma":[0.99737644,0.0007528132,0.0011522337,0.00010713764,0.00021691949,0.00039451697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066431717,0.00020301889,0.00029610668,0.00050433597,0.0002343424,0.00045969003,0.00018841207,0.00041883698,0.001664631],"category_scores_gemma":[0.0026502865,0.00019169816,0.00033597366,0.00037752092,0.00020710519,0.00028270308,0.00029034322,0.00052077457,0.0001774219],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018918229,0.000023982291,0.9990194,0.000004564951,0.000021613383,0.000039401664,0.000012513496,0.000017104361,0.00010901217,0.0000036740068,0.000024234067,0.0005353781],"study_design_scores_gemma":[0.000013007829,0.0001815623,0.9990496,0.0000035768974,0.000021313002,0.00037512672,0.000040990348,0.00019967605,0.00005055284,0.000009677557,0.000052823932,0.000002041303],"about_ca_topic_score_codex":0.00056767644,"about_ca_topic_score_gemma":0.0008204288,"teacher_disagreement_score":0.001664631,"about_ca_system_score_codex":0.0001261412,"about_ca_system_score_gemma":0.00013690717,"threshold_uncertainty_score":0.0055687428},"labels":[],"label_agreement":null},{"id":"W4405670959","doi":"10.1093/crocol/otae073","title":"Impact of Fatigue on Work Productivity, Activity Impairment, and Healthcare Resource Utilization in Inflammatory Bowel Disease","year":2024,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Janssen Pharmaceuticals; National Center for Advancing Translational Sciences; Chugai Pharmaceutical; Bristol-Myers Squibb Canada; Genentech; LEO Pharma; Australian Renewable Energy Agency; Bristol-Myers Squibb; Eli Lilly and Company; Ortho Dermatologics; Amgen; Boehringer Ingelheim; AbbVie; Novartis; Pfizer","keywords":"Work productivity; Inflammatory bowel disease; Productivity; Disease; Work (physics); Health care; Resource (disambiguation); Medicine; Business; Physical therapy; Intensive care medicine; Internal medicine; Engineering; Economics; Computer science; Economic growth; Mechanical engineering","score_opus":0.020744899378130933,"score_gpt":0.3042277678905848,"score_spread":0.28348286851245386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405670959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99468094,0.0028603713,0.00013548703,0.00023763048,0.000012064212,0.000010156691,0.0012868866,0.000005754528,0.00077067316],"genre_scores_gemma":[0.9990305,0.00029365034,0.000055977383,0.00003093845,0.000020324424,0.0000064641995,0.00049662887,0.0000010022252,0.000064501444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873036,0.0005473642,0.00019562393,0.0001099943,0.00022359093,0.00019305153],"domain_scores_gemma":[0.99450845,0.0012000048,0.0032418023,0.00013117521,0.00044246737,0.00047622217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017972908,0.00020664107,0.00034491732,0.0009136948,0.00021263235,0.00050507684,0.00022260431,0.00025546245,0.0014086162],"category_scores_gemma":[0.006245268,0.00011711373,0.0006581321,0.0011756036,0.00015634256,0.00042753952,0.0005856775,0.00039837274,0.00015201114],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059414793,0.000017552145,0.9970521,0.000027899865,0.000075187316,0.000019327386,0.000017933135,0.000089801484,0.000031602693,0.000005466319,0.00009017153,0.0025135337],"study_design_scores_gemma":[0.000002119285,0.000037380967,0.99964774,0.000014071332,0.000015429963,0.000057593723,0.00002025758,0.00011226077,0.000009244748,0.000007206782,0.000075326934,0.0000013239843],"about_ca_topic_score_codex":0.003300262,"about_ca_topic_score_gemma":0.0044304538,"teacher_disagreement_score":0.003300262,"about_ca_system_score_codex":0.0003857991,"about_ca_system_score_gemma":0.00028445854,"threshold_uncertainty_score":0.009505093},"labels":[],"label_agreement":null},{"id":"W4406812509","doi":"10.1093/crocol/otae083","title":"Certolizumab Pegol Treatment in Patients With Crohn’s Disease: Final Safety Data From the SECURE Registry","year":2024,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"UCB Pharma","keywords":"Medicine; Certolizumab pegol; Internal medicine; Odds ratio; Observational study; Incidence (geometry); Confidence interval; Adverse effect; Concomitant; Disease","score_opus":0.015008381614886235,"score_gpt":0.24938624551259436,"score_spread":0.23437786389770812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406812509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94718784,0.0019908566,0.0014296604,0.00029181835,0.000027698015,0.0003864085,0.04605372,0.000057428584,0.0025746187],"genre_scores_gemma":[0.9359743,0.0012695284,0.0017836151,0.00018243649,0.00007703314,0.00055685616,0.059730355,0.000021746064,0.0004041502],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99161035,0.0024285533,0.0022809405,0.0008483192,0.002513784,0.00031798412],"domain_scores_gemma":[0.9641175,0.006429607,0.021444475,0.004311121,0.002896723,0.00080065726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007877575,0.00027743148,0.00094998843,0.0012492166,0.0002893495,0.0009611273,0.0004695616,0.0004013756,0.0020618672],"category_scores_gemma":[0.014228884,0.0002943231,0.0009123981,0.0032956097,0.0002986595,0.0005521291,0.00078177045,0.0005921487,0.00068001944],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038043824,0.000119763405,0.9800934,0.00038926254,0.0004880111,0.00012440463,0.000109261004,0.0004935313,0.00045843876,0.00018304371,0.0030843208,0.010652131],"study_design_scores_gemma":[0.0011482317,0.0015567095,0.9818917,0.00026738935,0.000748976,0.0009060048,0.00019577403,0.00131285,0.0008907523,0.00030503175,0.010747613,0.00002895507],"about_ca_topic_score_codex":0.001332239,"about_ca_topic_score_gemma":0.0017226886,"teacher_disagreement_score":0.007877575,"about_ca_system_score_codex":0.0005290023,"about_ca_system_score_gemma":0.0017070092,"threshold_uncertainty_score":0.041661084},"labels":[],"label_agreement":null},{"id":"W4407272523","doi":"10.1093/crocol/otaf009","title":"Multimodal Lifestyle Intervention Improves Fatigue in Quiescent Inflammatory Bowel Disease: A Controlled Study","year":2024,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Maag Lever Darm Stichting; McMaster University; University of Pittsburgh","keywords":"Inflammatory bowel disease; Intervention (counseling); Medicine; Physical therapy; Disease; Internal medicine; Gastroenterology; Psychiatry","score_opus":0.007394069688567413,"score_gpt":0.26939630727070774,"score_spread":0.2620022375821403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407272523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820549,0.012257856,0.00043592733,0.0002695971,0.00023009139,0.0036176543,0.0003268347,0.000046415134,0.0007608931],"genre_scores_gemma":[0.9856023,0.0056134625,0.0014401483,0.0005015375,0.00056653266,0.005396255,0.00032119025,0.000006324041,0.00055219163],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99842095,0.00093975826,0.00019290965,0.00017917923,0.000121754,0.00014546886],"domain_scores_gemma":[0.998451,0.0006192092,0.00037544902,0.00010706176,0.00012008635,0.0003272555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024022004,0.0007727859,0.0023275698,0.0005466015,0.00063102297,0.0006107064,0.0006531753,0.0014937026,0.0042886133],"category_scores_gemma":[0.002456386,0.00037504706,0.0018166044,0.000731333,0.00077961636,0.00048084554,0.0004020124,0.0010284283,0.0002912662],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7966314,0.11022161,0.007733537,0.0061914357,0.0046285447,0.00013823013,0.00021173073,0.00022910937,0.004394237,0.00010122531,0.00068436674,0.06883455],"study_design_scores_gemma":[0.53728974,0.43815148,0.020693911,0.00032987518,0.0020782736,0.000046501515,0.00006961544,0.00028156498,0.0004138793,0.000050364775,0.00057633204,0.00001853292],"about_ca_topic_score_codex":0.0010823956,"about_ca_topic_score_gemma":0.0019362137,"teacher_disagreement_score":0.0042886133,"about_ca_system_score_codex":0.00042633363,"about_ca_system_score_gemma":0.0010852696,"threshold_uncertainty_score":0.014346838},"labels":[],"label_agreement":null},{"id":"W4407593379","doi":"10.1093/crocol/otaf013","title":"Tofacitinib for Hospitalized Acute Severe Ulcerative Colitis Management (The TRIUMPH Study)","year":2024,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; University of Manitoba; University of Alberta Hospital; Alberta Hospital Edmonton; Health Sciences Centre; McMaster University Medical Centre","funders":"Pfizer Canada; Pfizer","keywords":"Tofacitinib; Ulcerative colitis; Medicine; Intensive care medicine; Internal medicine; Disease","score_opus":0.008899398249892844,"score_gpt":0.2713860190936181,"score_spread":0.26248662084372526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407593379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98891383,0.005650702,0.000108891356,0.00068302685,0.00008714707,0.0008227805,0.0016363943,0.000016224509,0.002080931],"genre_scores_gemma":[0.9908789,0.0026942648,0.0006869303,0.00086521433,0.00043731794,0.0008496456,0.0029480995,0.000005794764,0.00063382706],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999297,0.00038398404,0.000049578633,0.0000725575,0.0000977359,0.00009914115],"domain_scores_gemma":[0.99874,0.00014552438,0.00047251966,0.000059068956,0.00009522029,0.00048764062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018725778,0.00048917567,0.00084642734,0.00024559253,0.0004974868,0.0007193465,0.00041383159,0.00057706726,0.0020384085],"category_scores_gemma":[0.001356274,0.00021648461,0.0008064574,0.0005025113,0.00031623847,0.00050845713,0.0004250647,0.0011184819,0.00026331187],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3420669,0.0133772185,0.47300908,0.003192103,0.004442447,0.00084529613,0.00042364787,0.000641114,0.006569955,0.0005801123,0.020922353,0.13392977],"study_design_scores_gemma":[0.23167257,0.10067961,0.6474152,0.0010774478,0.0040463465,0.0018582792,0.00040522913,0.0012315735,0.0010831105,0.00042290144,0.010025416,0.00008223227],"about_ca_topic_score_codex":0.0017847602,"about_ca_topic_score_gemma":0.0039839917,"teacher_disagreement_score":0.0020384085,"about_ca_system_score_codex":0.00054061954,"about_ca_system_score_gemma":0.001203803,"threshold_uncertainty_score":0.009903312},"labels":[],"label_agreement":null},{"id":"W4408142360","doi":"10.1093/crocol/otaf016","title":"Research Participation in Inflammatory Bowel Disease Studies: What Do Patients Want?","year":2025,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Mental Health and Patient Involvement","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Manitoba Health; University of Manitoba","funders":"Takeda Canada; Pfizer","keywords":"Inflammatory bowel disease; Medicine; Inflammatory Bowel Diseases; Gastroenterology; Internal medicine; Disease","score_opus":0.24426163921130473,"score_gpt":0.5295187038307297,"score_spread":0.285257064619425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408142360","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.447945,0.031501517,0.001120383,0.5075739,0.0009802948,0.00025012228,0.00044163698,0.000035185545,0.010151963],"genre_scores_gemma":[0.9179879,0.01454485,0.0022012217,0.062531665,0.0015425838,0.0002578649,0.00024707272,0.000020781441,0.00066613825],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.9637871,0.025868911,0.0035617363,0.0010934985,0.0039786096,0.0017101788],"domain_scores_gemma":[0.87779695,0.064279154,0.026408058,0.002322603,0.006686854,0.022506401],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.033752505,0.00017661037,0.0008030729,0.0011259087,0.0022205831,0.0039355606,0.0009137601,0.0045769718,0.0055720913],"category_scores_gemma":[0.103259616,0.00031215957,0.0006620848,0.0019578638,0.0032620498,0.005387554,0.003052298,0.0036470126,0.0010679354],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014142394,0.00070948695,0.65099025,0.006938261,0.00030596482,0.0017827922,0.04185646,0.0002148039,0.0016822272,0.002735054,0.04486915,0.24650136],"study_design_scores_gemma":[0.000743136,0.0024433988,0.5482851,0.018190062,0.00043606275,0.010358367,0.23065704,0.00090790715,0.0008232593,0.017116128,0.16962065,0.0004188674],"about_ca_topic_score_codex":0.0011391102,"about_ca_topic_score_gemma":0.002417711,"teacher_disagreement_score":0.033752505,"about_ca_system_score_codex":0.001327392,"about_ca_system_score_gemma":0.004400353,"threshold_uncertainty_score":0.17850244},"labels":[],"label_agreement":null},{"id":"W4408497622","doi":"10.1093/crocol/otaf021","title":"Racial Disparities in Utilization of Medications and Disease Outcomes in Inflammatory Bowel Disease Patients","year":2025,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Vedolizumab; Adalimumab; Ulcerative colitis; Inflammatory bowel disease; Internal medicine; Ustekinumab; Golimumab; Odds ratio; Infliximab; Pouchitis; Crohn's disease; Disease","score_opus":0.006301511030507384,"score_gpt":0.25685807383485415,"score_spread":0.2505565628043468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408497622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99836856,0.00038434647,0.000051561554,0.00019660941,0.0000062817585,0.0000042006986,0.00019846538,0.0000013729856,0.0007886447],"genre_scores_gemma":[0.99958223,0.00012164581,0.00003798721,0.00006073738,0.000009357748,0.0000031391107,0.00013232161,5.528582e-7,0.000051947816],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996377,0.0001358689,0.000035012723,0.000055171855,0.000055828485,0.00008036988],"domain_scores_gemma":[0.9991916,0.00014684738,0.00045092675,0.00002765292,0.000052812855,0.0001302288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051926007,0.000088882196,0.00016063525,0.00045501653,0.0002715409,0.00034860842,0.00012210809,0.00022087828,0.0017457803],"category_scores_gemma":[0.0017639903,0.00006343091,0.00022901269,0.00062742986,0.00011617951,0.00020585465,0.0003080563,0.00024702388,0.00009909478],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009135831,0.000043542044,0.9968207,0.000010130874,0.000062647414,0.000028653369,0.00008322284,0.000049160375,0.00008931087,0.000105214865,0.00017907331,0.0024369617],"study_design_scores_gemma":[0.0000114283175,0.000049404596,0.99881554,0.000018094877,0.000043487697,0.00009205529,0.00015779918,0.00027223676,0.000048895698,0.0001323084,0.00035629774,0.0000025585891],"about_ca_topic_score_codex":0.005405808,"about_ca_topic_score_gemma":0.006262841,"teacher_disagreement_score":0.005405808,"about_ca_system_score_codex":0.00026099366,"about_ca_system_score_gemma":0.0002767301,"threshold_uncertainty_score":0.010748684},"labels":[],"label_agreement":null},{"id":"W4408547160","doi":"10.1093/crocol/otaf011","title":"US and European Patient and Health Care Professional Perspectives on Fatigue in Ulcerative Colitis and Crohn’s Disease: Results From the Communicating Needs and Features of Inflammatory Bowel Disease Experiences Survey","year":2025,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Eli Lilly and Company","keywords":"Medicine; Ulcerative colitis; Quality of life (healthcare); Disease; Crohn's disease; Health care; Health professionals; Physical therapy; Family medicine; Internal medicine; Nursing","score_opus":0.013257514185753055,"score_gpt":0.2842826005898391,"score_spread":0.27102508640408607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408547160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979225,0.00024664256,0.000028587652,0.00025523696,0.000007536201,0.000018908968,0.00039428828,0.0000014783468,0.0011248703],"genre_scores_gemma":[0.9986702,0.00022812591,0.00009887932,0.0002524288,0.00001186041,0.000050378414,0.0004897001,0.0000019139868,0.00019643508],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960238,0.0023707834,0.00047564143,0.00018228861,0.00044252077,0.00050491065],"domain_scores_gemma":[0.99211323,0.0025592202,0.0031000164,0.00019611511,0.0009644466,0.0010669414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049481643,0.0001848027,0.00037080896,0.0012709856,0.00071936875,0.0009548394,0.0002479836,0.00073214254,0.0013577744],"category_scores_gemma":[0.01099952,0.0001918728,0.00083820743,0.0019674413,0.0005062541,0.0011479859,0.0020259782,0.00060259126,0.00016072227],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025030534,0.00015735501,0.9705602,0.00009808522,0.0001248267,0.00016059005,0.01659712,0.00008303563,0.0001233075,0.00007645058,0.0012824343,0.010486257],"study_design_scores_gemma":[0.000016248418,0.00014383355,0.98239225,0.000046907164,0.000022197559,0.00016646457,0.01563181,0.000095419055,0.00003740721,0.000024264482,0.0014115752,0.000011706801],"about_ca_topic_score_codex":0.009265913,"about_ca_topic_score_gemma":0.014008283,"teacher_disagreement_score":0.009265913,"about_ca_system_score_codex":0.00082991814,"about_ca_system_score_gemma":0.0006930395,"threshold_uncertainty_score":0.026168704},"labels":[],"label_agreement":null},{"id":"W4409689439","doi":"10.1093/crocol/otaf029","title":"Pregnant Pause? Not for IBD Care—A Single Tertiary Care Center Prospective Cohort Study Affirming IBD Management in Pregnancy","year":2025,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Queen's University","funders":"","keywords":"Tertiary care; Medicine; Pregnancy; Prospective cohort study; Obstetrics; Cohort study; Cohort; Family medicine; Internal medicine","score_opus":0.015027364276208313,"score_gpt":0.303788734187027,"score_spread":0.2887613699108187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409689439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981974,0.00042440862,0.00010554904,0.00022076238,0.000014602256,0.00004907227,0.0006425679,0.0000039569586,0.00034168223],"genre_scores_gemma":[0.99901927,0.00021032995,0.00011725742,0.00017559434,0.000015165752,0.00003540035,0.00034281536,0.0000034343884,0.000080785525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983557,0.000505728,0.00019412278,0.0004139592,0.0002666784,0.000263823],"domain_scores_gemma":[0.99689037,0.00049783057,0.0012924545,0.00045519182,0.00023974344,0.00062449864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001872626,0.0002743602,0.00052294036,0.0006946212,0.0015029709,0.0013223875,0.00077103346,0.00053413457,0.0013442182],"category_scores_gemma":[0.004667561,0.0005792674,0.00068327214,0.0018424331,0.00043093917,0.0007004113,0.0009803524,0.0012331036,0.00023521521],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000070454975,0.000038222686,0.99854076,0.000009444777,0.000046214405,0.00018925691,0.00027657676,0.000009179352,0.000059206952,0.00002296343,0.00016435463,0.0005733707],"study_design_scores_gemma":[0.000026638785,0.0001794833,0.9973455,0.00003732235,0.00006787988,0.00073072215,0.0011056163,0.00014282415,0.000035495912,0.000031560423,0.00028793933,0.000009017102],"about_ca_topic_score_codex":0.030620715,"about_ca_topic_score_gemma":0.029953033,"teacher_disagreement_score":0.030620715,"about_ca_system_score_codex":0.001058018,"about_ca_system_score_gemma":0.0019026044,"threshold_uncertainty_score":0.060885012},"labels":[],"label_agreement":null},{"id":"W4410105772","doi":"10.1093/crocol/otaf024","title":"Global Patterns of <i>Clostridioides difficile</i> Infection in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Prevalence, Epidemiology, and Risk Factors","year":2025,"lang":"en","type":"review","venue":"Crohn s & Colitis 360","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Incidence (geometry); Odds ratio; Internal medicine; Meta-analysis; Inflammatory bowel disease; Population; Epidemiology; Disease; Environmental health","score_opus":0.03648110628675085,"score_gpt":0.3361699554526039,"score_spread":0.2996888491658531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410105772","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004700788,0.99385047,0.0003446291,0.00013623256,0.00008529307,0.00017965265,0.0005285013,0.000016343549,0.00015805109],"genre_scores_gemma":[0.14508107,0.849716,0.0023480826,0.0005628525,0.00016581205,0.0008630192,0.0010439121,0.000025876245,0.00019338605],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9895291,0.0042434847,0.0036202315,0.0011197085,0.0011969904,0.00029056842],"domain_scores_gemma":[0.98168695,0.012346293,0.0037414955,0.000499776,0.001496429,0.00022910869],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014728523,0.00258818,0.018858112,0.00907086,0.0006363401,0.0032507975,0.0018946932,0.0017723638,0.002070062],"category_scores_gemma":[0.028008375,0.001433266,0.039894354,0.010154032,0.0006815156,0.0014926199,0.0014932461,0.0014861128,0.00020728556],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010753993,0.000020549083,0.0077036773,0.37787157,0.60169923,0.00011890816,0.00009650134,0.0005175282,0.00019946785,0.00009285507,0.00051940914,0.010084899],"study_design_scores_gemma":[0.00023814815,0.00013082413,0.0053107156,0.02975367,0.96291804,0.00012386273,0.000047039095,0.00015659224,0.00008330403,0.000097693584,0.00111996,0.000020178253],"about_ca_topic_score_codex":0.007931527,"about_ca_topic_score_gemma":0.018161599,"teacher_disagreement_score":0.018858112,"about_ca_system_score_codex":0.0025417202,"about_ca_system_score_gemma":0.0043821908,"threshold_uncertainty_score":0.07789278},"labels":[],"label_agreement":null},{"id":"W4410314435","doi":"10.1093/crocol/otaf035","title":"The Spectrum of Psychiatric Comorbidity in Individuals With Inflammatory Bowel Disease","year":2025,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Manitoba; Manitoba Health; Health Sciences Centre","funders":"Canadian Institutes of Health Research; Pfizer Foundation; Arthritis Society; Crohn's and Colitis Canada; Multiple Sclerosis Society; Dalhousie University; Biogen; Pfizer; U.S. Department of Defense","keywords":"Psychiatric comorbidity; Comorbidity; Inflammatory bowel disease; Medicine; Psychiatry; Psychiatric Disease; Disease; Internal medicine","score_opus":0.0041875881414529395,"score_gpt":0.23076089782543413,"score_spread":0.22657330968398118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410314435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99656844,0.0013537697,0.00008249787,0.00020415477,0.000012442351,0.000016024223,0.00036510287,0.000005156982,0.0013923023],"genre_scores_gemma":[0.99905306,0.0004004051,0.00013336535,0.000060337396,0.00001906875,0.000010438135,0.0002469213,8.923456e-7,0.00007553353],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994615,0.00015881656,0.0000795016,0.00008131524,0.0001127957,0.0001060491],"domain_scores_gemma":[0.99924785,0.00011085616,0.00038529994,0.000019024652,0.0000730112,0.0001638134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032836912,0.0001844997,0.000255861,0.0008131972,0.000533587,0.0004691938,0.00018850299,0.0002768742,0.0016800362],"category_scores_gemma":[0.0016085283,0.00013619961,0.00023516675,0.0007936618,0.00016854344,0.00030978274,0.0006753648,0.0003690381,0.00015279879],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056040608,0.000017722521,0.9958597,0.000025750238,0.000027196245,0.0002842909,0.00010905724,0.000022632088,0.00019913171,0.000026129044,0.00011317168,0.0032591547],"study_design_scores_gemma":[0.000002421835,0.000025358271,0.9985624,0.000018702172,0.0000105193685,0.0009961638,0.00017240185,0.000046877605,0.000016775457,0.000028504572,0.000117961834,0.0000019014022],"about_ca_topic_score_codex":0.0028505384,"about_ca_topic_score_gemma":0.005971099,"teacher_disagreement_score":0.0028505384,"about_ca_system_score_codex":0.0002785802,"about_ca_system_score_gemma":0.00022831546,"threshold_uncertainty_score":0.0056678653},"labels":[],"label_agreement":null},{"id":"W4411272591","doi":"10.1093/crocol/otaf043","title":"Fecal Calprotectin and C-Reactive Protein Association With Histologic and Endoscopic Endpoints in Mirikizumab-Treated Patients With Ulcerative Colitis","year":2025,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Eli Lilly and Company","keywords":"Calprotectin; Ulcerative colitis; Gastroenterology; Feces; Medicine; Internal medicine; C-reactive protein; Colitis; Inflammatory bowel disease; Inflammation; Biology; Disease; Microbiology","score_opus":0.002991924052892428,"score_gpt":0.2035348890735019,"score_spread":0.20054296502060948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411272591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99939895,0.00035788683,0.000040375584,0.00002244845,0.0000024552953,0.000008949889,0.00004687783,0.0000026513003,0.00011936691],"genre_scores_gemma":[0.99969554,0.00005395529,0.000077658646,0.000016424752,0.0000052472233,0.0000079784595,0.00008789562,7.089476e-7,0.00005471039],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996555,0.00014836765,0.00004126985,0.00006175307,0.000053122087,0.000039979368],"domain_scores_gemma":[0.99897885,0.0002395959,0.0004856458,0.000050829443,0.00006753286,0.00017761161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089257903,0.0002568979,0.00050135463,0.0003194855,0.00020357424,0.00035719207,0.00019253328,0.00040117037,0.0006689452],"category_scores_gemma":[0.001340637,0.00016498519,0.00040365776,0.00034696306,0.00015332653,0.00023242008,0.00017163306,0.0005759197,0.00010930265],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010713124,0.00044116154,0.97788143,0.000052044106,0.0001706075,0.00014259752,0.00006837671,0.00014060758,0.003557441,0.000013353788,0.00013299323,0.006686252],"study_design_scores_gemma":[0.0001605503,0.0016654972,0.9971717,0.0000065830454,0.00006595881,0.00021983712,0.00003249634,0.0003427537,0.0001946468,0.000011714436,0.00012458762,0.0000037896377],"about_ca_topic_score_codex":0.00048233126,"about_ca_topic_score_gemma":0.001013626,"teacher_disagreement_score":0.00089257903,"about_ca_system_score_codex":0.00023134713,"about_ca_system_score_gemma":0.0001557024,"threshold_uncertainty_score":0.0047204494},"labels":[],"label_agreement":null},{"id":"W4412124270","doi":"10.1093/crocol/otaf031","title":"Real-World Clinical Effectiveness and Safety of Vedolizumab and Ustekinumab in Biologic-Naïve Patients With Early or Late Crohn’s Disease: Results From the EVOLVE Expansion Study","year":2025,"lang":"en","type":"article","venue":"Crohn s & Colitis 360","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thermo Fisher Scientific (Canada); St. Paul's Hospital","funders":"Takeda Foundation","keywords":"Vedolizumab; Ustekinumab; Crohn's disease; Medicine; Disease; Dermatology; Internal medicine; Adalimumab","score_opus":0.011623848038346542,"score_gpt":0.28653118877797956,"score_spread":0.274907340739633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412124270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957331,0.002683727,0.000097123004,0.0000663463,0.0000064580336,0.00007569828,0.000709187,0.0000053405784,0.000623016],"genre_scores_gemma":[0.99751186,0.0005000808,0.0002725336,0.0001135138,0.000044235785,0.00007106928,0.0013590977,0.0000025479374,0.00012505206],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99482393,0.0032251582,0.00050184363,0.0004729251,0.00083014765,0.0001459752],"domain_scores_gemma":[0.9891774,0.0035704474,0.0051569077,0.00051408773,0.0007656949,0.0008155297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0062734624,0.0002569415,0.0008285863,0.00047866124,0.00021960698,0.000865738,0.00035558638,0.00039668538,0.0009383958],"category_scores_gemma":[0.006593803,0.00014805925,0.0009635322,0.0006230322,0.0003952593,0.00062654517,0.000556188,0.00050534983,0.00013955169],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07515757,0.0022631094,0.85836095,0.0008288257,0.0030516787,0.0001403119,0.0002780797,0.0010404458,0.0024876832,0.00013435546,0.0009793056,0.05527751],"study_design_scores_gemma":[0.0075205723,0.019276025,0.96518064,0.00014345246,0.0016058505,0.00047294385,0.0001941339,0.0012990432,0.0015942566,0.00007546296,0.0025991283,0.00003850626],"about_ca_topic_score_codex":0.00080870173,"about_ca_topic_score_gemma":0.0013921506,"teacher_disagreement_score":0.0062734624,"about_ca_system_score_codex":0.0006560229,"about_ca_system_score_gemma":0.0005172742,"threshold_uncertainty_score":0.033177614},"labels":[],"label_agreement":null}]}